Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Cytoplasmic Ribosomal Proteins WP477,9.637626253445118e-07,3.24816986496091,44.99501583805833,"['RPL4', 'RPL3', 'RPL32', 'RPL34', 'RPLP1', 'RPL12', 'RPL36A', 'RPL7', 'RPS14', 'RPS16', 'RPS18', 'RPS6KA2', 'RPL36', 'RPL35', 'RPLP2', 'RPL38', 'RPL37', 'RPS10', 'RPS12', 'RPL19', 'RPS9', 'RPS6', 'RPL23A', 'RPS6KB1', 'RPL27A', 'RPL37A', 'RPL27', 'RPS20', 'RPL26', 'RPS21', 'RPS24']",0.0005059753783058687,0,0,31
2,Mesodermal commitment pathway WP2857,1.0168564147440446e-05,2.6883715139442232,30.906082253682413,"['SETD2', 'BMPR2', 'NCAPG2', 'NLK', 'PHF6', 'ACACA', 'MBTD1', 'EPB41L5', 'UBR5', 'RPL38', 'JAK2', 'JARID2', 'KDM6A', 'SMAD2', 'SMAD4', 'PBX3', 'ELP4', 'ZFHX4', 'EMSY', 'PBX1', 'PIAS1', 'PARP8', 'EXT1', 'LATS1', 'EXT2', 'CCDC88A', 'TOX3', 'MEIS1', 'DDAH1', 'RARB', 'WDFY2', 'AHDC1', 'BMPR1A']",0.0026692480887031173,0,0,33
3,Endoderm differentiation WP2853,2.4208529383883216e-05,2.546013315160411,27.061080411318144,"['NCAPG2', 'NR3C1', 'NLK', 'PHF6', 'FOXO1', 'ACACA', 'CDC73', 'MBTD1', 'EPB41L5', 'UBR5', 'JARID2', 'BPTF', 'SMAD2', 'SMAD4', 'PBX3', 'CDYL', 'ELP4', 'ZFHX4', 'EMSY', 'PBX1', 'PIAS1', 'PARP8', 'EXT1', 'TNRC6C', 'TOX3', 'DDAH1', 'APC', 'RFX7', 'SP4', 'WDFY2', 'NAA15', 'AHDC1', 'BMPR1A']",0.004236492642179563,0,0,33
4,Pathways affected in adenoid cystic carcinoma WP3651,5.396162597421999e-05,3.231526836894216,31.756981371643043,"['SETD2', 'CREBBP', 'FBXW7', 'CNTN6', 'KMT2C', 'ATRX', 'PTEN', 'ERBIN', 'ARID4B', 'FOXO3', 'FOXP2', 'NCOR1', 'NFIB', 'KAT6A', 'NSD1', 'EP300', 'TLK1', 'ATM', 'MAML3', 'RAF1', 'KDM6A']",0.007082463409116373,0,0,21
5,Regulation of Microtubule Cytoskeleton WP2038,8.331857799115681e-05,3.8933333333333335,36.56945320663673,"['GSK3B', 'ROCK1', 'PTEN', 'PRKCA', 'TIAM1', 'DIAPH1', 'CLIP1', 'APC', 'TAOK1', 'CAMK4', 'GNAQ', 'MAPKAPK2', 'ABL1', 'CLASP1', 'MARK2', 'MARK1']",0.008748450689071464,0,0,16
6,Ectoderm Differentiation WP2858,0.0003698278794177946,2.1865192111730503,17.27890870519233,"['NLGN1', 'ARHGDIG', 'NLK', 'JAKMIP1', 'WDR44', 'SOCS2', 'TRPM2', 'NARS2', 'FYN', 'CTNNA2', 'CDON', 'TTC14', 'BCAS3', 'SMAD4', 'KCNK10', 'ELOVL4', 'C1GALT1', 'ZFHX4', 'RGMA', 'AHI1', 'TOX3', 'PTPRB', 'RIT1', 'GLB1', 'NF2', 'KIFC3', 'PDE7A', 'OGT', 'TRIM33', 'ASTN1', 'BMPR1A']",0.027737090956334594,0,0,31
7,TGF-beta Signaling Pathway WP366,0.0003698278794177946,2.1865192111730503,17.27890870519233,"['CITED1', 'ROCK1', 'ZFYVE9', 'HDAC1', 'CUL1', 'MAPK8', 'PRKAR2A', 'EP300', 'MAPK1', 'BTRC', 'MAP3K7', 'SPTBN1', 'PDK1', 'MEF2A', 'SMAD2', 'MAP2K4', 'SMAD4', 'CREBBP', 'FN1', 'NUP153', 'PIAS2', 'PTK2', 'PIAS1', 'ZEB2', 'ITCH', 'ZFYVE16', 'RBL1', 'ZEB1', 'SP1', 'RAF1', 'SOS1']",0.027737090956334594,0,0,31
8,Fragile X Syndrome  WP4549,0.00043627967645966544,2.1603056147832267,16.714775061635198,"['GRIA1', 'CYFIP1', 'GRIA2', 'GABRB2', 'ABCD3', 'KCNC1', 'PTEN', 'PIK3CB', 'RAP1GAP', 'GPHN', 'GRM1', 'RPTOR', 'GRIN2A', 'MKNK1', 'MAPK1', 'FYN', 'PDK1', 'EPHA4', 'GAD1', 'PRKCA', 'DICER1', 'GRIN2B', 'GRIP2', 'DNM2', 'CREB1', 'RPS6KB1', 'CAMK4', 'PICK1', 'RAF1', 'SOS1', 'SHANK1']",0.028630853767665543,0,0,31
9,Leptin signaling pathway WP2034,0.0006447090857515838,2.5561262376237623,18.77912170014938,"['GSK3B', 'PTPN1', 'STAT5B', 'PRKAA1', 'CHUK', 'ROCK1', 'RPS6', 'PTEN', 'FOXO1', 'ACACA', 'PTK2', 'SOCS2', 'MAPK8', 'CREB1', 'RPS6KB1', 'SP1', 'MAPK1', 'FYN', 'JAK2', 'SOS1', 'RAF1']",0.03752255131291623,0,0,21
10,Hematopoietic Stem Cell Gene Regulation by GABP alpha/beta Complex WP3657,0.0007147152631031663,5.244094488188976,37.9862609012094,"['SMAD4', 'CREBBP', 'DNMT3A', 'PTEN', 'EP300', 'ATM', 'FOXO3', 'ZFX', 'ETV6']",0.03752255131291623,0,0,9
11,Androgen receptor signaling pathway WP138,0.001280647450983544,2.277746048277368,15.170675881502671,"['RB1', 'GSK3B', 'CREBBP', 'SMAD4', 'ROCK1', 'HDAC1', 'PTEN', 'RNF6', 'PARK7', 'NR2C2', 'PIAS2', 'FOXO1', 'EGFR', 'PTK2', 'PIAS1', 'NCOR2', 'KAT2B', 'CREB1', 'NCOR1', 'SP1', 'ZNF318', 'EP300', 'RAD9A']",0.05864315617241445,0,0,23
12,Energy Metabolism WP1541,0.001340414998226616,2.9170779861796645,19.295817490440587,"['MEF2A', 'GSK3B', 'PRKAA1', 'HDAC1', 'NRF1', 'TFB1M', 'FOXO3', 'FOXO1', 'PPP3CC', 'PPP3R2', 'CREB1', 'CAMK4', 'EP300', 'PPARA', 'PPARGC1A']",0.05864315617241445,0,0,15
13,Circadian rhythm related genes WP3594,0.0018643337845658263,1.8322021034370595,11.515118156002247,"['GSK3B', 'NLGN1', 'PRKAA1', 'PHLPP1', 'KMT2A', 'HDAC1', 'SUV39H1', 'CUL1', 'PTEN', 'RBM4B', 'RORA', 'AHR', 'RORB', 'PPP1CC', 'MAPK8', 'EP300', 'DRD1', 'BTRC', 'PPARGC1A', 'DRD4', 'OPN3', 'FBXW11', 'KCNH7', 'NTRK3', 'ARNT', 'BTBD9', 'NCOR1', 'PER3', 'CREB1', 'ADORA2A', 'GNAQ', 'TOP1', 'PPARA', 'CLOCK', 'OGT', 'LGR4']",0.07529040283823529,0,0,36
14,Common Pathways Underlying Drug Addiction WP2636,0.0027580792847688527,2.915187376725838,17.17984274690115,"['GRIA1', 'GRIA2', 'PRKCA', 'GRM1', 'PPP1CC', 'GRIN2A', 'CREB1', 'CAMK4', 'MAPK1', 'DRD1', 'RAF1', 'GRIA3', 'DRD4']",0.10342797317883197,0,0,13
15,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.0031442621067891167,1.8345679735308758,10.571103621914645,"['GRIA1', 'CYFIP1', 'GRIA2', 'GSK3B', 'PRKAA1', 'DOCK3', 'FOXO3', 'MAPK8', 'NCK2', 'MAPK1', 'FYN', 'JAK2', 'GRIA3', 'MEF2A', 'STAT5B', 'LINGO1', 'MAP3K1', 'KSR1', 'CHUK', 'KIDINS220', 'NTRK3', 'RPS6', 'RANBP9', 'EEF2', 'GRIN2B', 'TIAM1', 'CREB1', 'RPS6KB1', 'APC', 'CAMK4', 'RAF1', 'CDK5R1']",0.11004917373761909,0,0,32
16,Follicle Stimulating Hormone (FSH) signaling pathway WP2035,0.003555821206436529,4.235209944998435,23.883065655244856,"['CREB1', 'RPS6KB1', 'RPS6', 'MAPK1', 'PRKCA', 'SGK1', 'RAF1', 'FOXO1']",0.11667538333619862,0,0,8
17,Histone Modifications WP2369,0.004505568060411407,2.7065018315018317,14.62171727392533,"['KMT2E', 'SETD2', 'KMT2A', 'EED', 'SUV39H1', 'KMT2C', 'SETD1A', 'SETDB2', 'EHMT1', 'ASH1L', 'SETBP1', 'NSD1', 'SMYD3']",0.1361617759090327,0,0,13
18,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.004693349342613975,1.8591428442397147,9.967996645023263,"['GSK3B', 'PRKAA1', 'PIK3R4', 'PIK3R3', 'PIK3CB', 'FOXO3', 'CBL', 'FOXO1', 'RPTOR', 'MAPK8', 'RPS6KA2', 'MAPK1', 'MAP3K8', 'MAP3K9', 'MAP3K7', 'MAP3K5', 'MAP4K4', 'MAP2K4', 'PTPN1', 'MAP3K1', 'INSR', 'SLCO1C1', 'MLXIPL', 'RPS6KB1', 'MAP3K10', 'RAF1', 'SOS1', 'SOS2']",0.1361617759090327,0,0,28
19,Synaptic signaling pathways associated with autism spectrum disorder WP4539,0.004927759509088802,2.5507523433645782,13.551817783020228,"['GSK3B', 'PRKAA1', 'PTEN', 'PIK3R3', 'PIK3CB', 'CACNA1C', 'GRIN2B', 'GRM1', 'RPTOR', 'GRIN2A', 'GRIN3A', 'RPS6KB1', 'CAMK4', 'MAPK1']",0.1361617759090327,0,0,14
20,ErbB signaling pathway WP673,0.005564242096148383,2.006655522535909,10.41734043244784,"['GSK3B', 'MAP2K4', 'STAT5B', 'PIK3R3', 'PRKCA', 'PIK3CB', 'NRG2', 'CBL', 'FOXO1', 'EGFR', 'PTK2', 'MAPK8', 'RPS6KB1', 'NCK2', 'ABL1', 'MAPK1', 'ABL2', 'SOS1', 'RAF1', 'PAK3', 'SOS2', 'PAK5']",0.14254645970072075,0,0,22
21,MECP2 and Associated Rett Syndrome WP3584,0.00570185838802883,2.1877162629757785,11.303849257208268,"['GRIA1', 'RBFOX1', 'HDAC1', 'FUS', 'GAD1', 'RPS6', 'PTEN', 'TET2', 'GABRR2', 'FUT8', 'CREB1', 'NCOR1', 'SP1', 'SP3', 'SGK1', 'GRIA3', 'CDON', 'FKBP5']",0.14254645970072075,0,0,18
22,Prolactin Signaling Pathway WP2037,0.006749833847421394,2.142887407063666,10.710659959683227,"['GSK3B', 'PTPN1', 'STAT5B', 'RPS6', 'PIK3CB', 'GAB2', 'CBL', 'PTK2', 'SOCS2', 'MAPK8', 'RPS6KB1', 'RPS6KA2', 'MAPK1', 'FYN', 'JAK2', 'SOS1', 'RAF1', 'YWHAG']",0.15115075624733482,0,0,18
23,PKC-gamma calcium signaling pathway in ataxia WP4760,0.007294734623083448,3.583033788641265,17.630684930502696,"['GRIA1', 'GRIA2', 'PLCB4', 'GNAQ', 'ATP2B2', 'GRM1', 'GRIA3', 'PDK1']",0.15115075624733482,0,0,8
24,Mitochondrial Gene Expression WP391,0.007345714176872269,4.074729596853491,20.021747168902216,"['MYEF2', 'CREB1', 'SP1', 'CAMK4', 'NRF1', 'TFB1M', 'PPARGC1A']",0.15115075624733482,0,0,7
25,Phosphodiesterases in neuronal function WP4222,0.007457858839244636,2.4003018079456746,11.757847021873163,"['GRIA1', 'GUCY1A2', 'GUCY1A1', 'GRIN2B', 'ADCY5', 'GRIN2A', 'CREB1', 'ADCY9', 'ADORA2A', 'PDE6C', 'PDE5A', 'DRD1', 'PDE7A', 'PDE9A']",0.15115075624733482,0,0,14
26,Insulin Signaling WP481,0.007485561261772771,1.6918641224575384,8.28130144957156,"['GSK3B', 'PRKAA1', 'PIK3R4', 'PTEN', 'PIK3R3', 'PIK3CB', 'FOXO3', 'CBL', 'FOXO1', 'GYS2', 'CYTH3', 'MAPK8', 'RPS6KA2', 'MAPK1', 'MAP3K8', 'MAP3K9', 'MAP3K7', 'GYG1', 'MAP3K5', 'MAP4K4', 'MAP2K4', 'PTPN1', 'MAP3K1', 'INSR', 'PRKCA', 'INPP4A', 'RPS6KB1', 'MAP3K10', 'RAF1', 'SOS1', 'SGK1', 'SOS2', 'ARF6']",0.15115075624733482,0,0,33
27,IL-3 signaling pathway WP286,0.010099748191565384,2.497078082095332,11.474685039415355,"['HCK', 'STAT5B', 'MAPK8', 'IL5RA', 'MAPK1', 'FYN', 'ENPP3', 'GAB2', 'JAK2', 'SOS1', 'RAF1', 'CBL']",0.19378803853331522,0,0,12
28,Joubert Syndrome WP4656,0.010858616858342256,2.0187459599224304,9.130376826204317,"['INVS', 'CEP120', 'ARMC9', 'MYO5A', 'CPLANE1', 'RPGRIP1L', 'AHI1', 'NIN', 'KIAA0586', 'SUFU', 'TMEM67', 'MYO6', 'INPP5E', 'NPHP4', 'ATM', 'CEP97', 'CEP290', 'PIBF1']",0.19378803853331522,0,0,18
29,Kit receptor signaling pathway WP304,0.010923496886702855,2.266567998684427,10.23772303226658,"['STAT5B', 'RPS6', 'PRKCA', 'GAB2', 'FOXO3', 'CBL', 'MAPK8', 'RPS6KB1', 'EP300', 'MAPK1', 'FYN', 'JAK2', 'SOS1', 'RAF1']",0.19378803853331522,0,0,14
30,AGE/RAGE pathway WP2324,0.011073602201903726,2.1859575518262586,9.843784773870743,"['SMAD2', 'STAT5B', 'CHUK', 'ROCK1', 'INSR', 'PRKCA', 'FOXO1', 'EGFR', 'DIAPH1', 'MAPK8', 'SP1', 'MAPK1', 'JAK2', 'EZR', 'RAF1']",0.19378803853331522,0,0,15
31,PI3K-AKT-mTOR signaling pathway and therapeutic opportunities WP3844,0.012045460051913034,2.911417322834646,12.865749522417472,"['RPTOR', 'GSK3B', 'PTEN', 'TFEB', 'PIK3R3', 'PIK3CB', 'FOXO3', 'FOXO1', 'PDK1']",0.2039956944275594,0,0,9
32,Ciliopathies WP4803,0.012863611601782421,1.6019898098590417,6.9740267596791865,"['INVS', 'IFT172', 'CEP120', 'PIK3R4', 'PKD2', 'PKD1', 'TTBK2', 'SUFU', 'TMEM67', 'INPP5E', 'HYDIN', 'NEK1', 'NPHP4', 'PIBF1', 'CEP290', 'CEP78', 'IFT140', 'SCLT1', 'IFT122', 'DNAAF5', 'CPLANE1', 'RPGRIP1L', 'DNAAF4', 'AHI1', 'WDR60', 'KIAA0586', 'NME9', 'ALMS1', 'EFHC1', 'CCDC65', 'ATXN10', 'CCDC151', 'KIZ', 'SDCCAG8']",0.20575938850400022,0,0,34
33,Regulation of Actin Cytoskeleton WP51,0.013389581670750285,1.6853544742677748,7.2694029856242866,"['NCKAP1', 'ROCK1', 'PIK3R4', 'PIK3R3', 'PIK3CB', 'ARHGAP35', 'FGD1', 'EGFR', 'GNA13', 'PIP4K2A', 'MAPK1', 'PAK3', 'MYH10', 'WASF2', 'PAK5', 'PPP1R12A', 'GSN', 'ACTN1', 'FN1', 'PTK2', 'DIAPH1', 'FGF14', 'APC', 'EZR', 'RAF1', 'SOS1', 'ARHGEF7', 'SOS2']",0.20575938850400022,0,0,28
34,IL-2 signaling pathway WP49,0.013508136251870115,2.64715097802247,11.39456367790896,"['STAT5B', 'RPS6KB1', 'RPS6', 'MAPK1', 'FYN', 'GAB2', 'FOXO3', 'CBL', 'SOS1', 'RAF1']",0.20575938850400022,0,0,10
35,Cell cycle WP179,0.013717292566933348,1.7893954410307236,7.674892426890454,"['RB1', 'SMAD2', 'GSK3B', 'SMAD4', 'HDAC1', 'CUL1', 'CDC7', 'CDC14A', 'ANAPC10', 'ANAPC11', 'ORC5', 'STAG2', 'RBL1', 'DBF4', 'TFDP2', 'CDC27', 'ORC2', 'ABL1', 'EP300', 'ATM', 'SKP2', 'YWHAG', 'YWHAH']",0.20575938850400022,0,0,23
36,Canonical and non-canonical TGF-B signaling WP3874,0.015192022871445153,3.879115479115479,16.241797548425904,"['SMAD2', 'GREM1', 'SMAD4', 'MAPK8', 'BMPR2', 'BMPR1A']",0.216688259205029,0,0,6
37,Gastrin signaling pathway WP4659,0.015454513183526274,1.765700798080434,7.362714893864005,"['GSK3B', 'YES1', 'CHUK', 'ROCK1', 'PRKCE', 'RPS6', 'PIK3R3', 'PRKCA', 'FOXO3', 'CLDN1', 'FOXO1', 'PTK2', 'EGFR', 'MAPK8', 'CREB1', 'RPS6KB1', 'SP1', 'GNAQ', 'MAPK1', 'FYN', 'RAF1', 'JAK2', 'SOS1']",0.216688259205029,0,0,23
38,Chemokine signaling pathway WP3929,0.01568410257103067,1.7164157329598506,7.131892150706667,"['GSK3B', 'ROCK1', 'GNAI3', 'PIK3R3', 'PIK3CB', 'FOXO3', 'RASGRP2', 'CX3CL1', 'ADCY5', 'GRK5', 'GRK4', 'MAPK1', 'JAK2', 'STAT5B', 'CHUK', 'PTK2', 'TIAM2', 'TIAM1', 'HCK', 'ADCY9', 'PLCB4', 'ELMO1', 'RAF1', 'SOS1', 'SOS2']",0.216688259205029,0,0,25
39,Male infertility WP4673,0.016946060303253997,1.801266744321491,7.345061253316299,"['USP8', 'CREBBP', 'PACRG', 'CCNT2', 'ABCB1', 'INSR', 'CXXC1', 'PEX10', 'AHR', 'TEX15', 'CHD2', 'PUM2', 'ABLIM1', 'EP300', 'SLC16A7', 'HLA-DRA', 'ATM', 'RGS9', 'CLOCK', 'SOX5', 'POLG']",0.22749650666666096,0,0,21
40,EGF/EGFR signaling pathway WP437,0.017437908834902822,1.5836532215201087,6.412384154145245,"['RALA', 'ROCK1', 'SH3KBP1', 'PTEN', 'PLD1', 'CBL', 'FOXO1', 'EGFR', 'GJA1', 'ATXN2', 'MAPK8', 'RPS6KA2', 'ABL1', 'NCK2', 'MAPK1', 'JAK2', 'MEF2A', 'USP8', 'STAT5B', 'MAP3K1', 'PRKCA', 'GAB2', 'PTK2', 'ITCH', 'CREB1', 'RPS6KB1', 'SP1', 'RAF1', 'SOS1', 'STAM2', 'SOS2', 'ARF6']",0.22749650666666096,0,0,32
41,IL-6 signaling pathway WP364,0.017766393853967808,2.3727969348659004,9.563431319419358,"['GSK3B', 'MAP2K4', 'HCK', 'CREBBP', 'RPS6KB1', 'HDAC1', 'MAPK1', 'NLK', 'JAK2', 'SOS1', 'MAP3K7']",0.22749650666666096,0,0,11
42,TNF-alpha signaling pathway WP231,0.0184458320314244,1.846439169139466,7.372678052810352,"['MAP2K4', 'CREBBP', 'MAP3K1', 'KSR1', 'CHUK', 'FBXW11', 'CUL1', 'OTUD7B', 'KSR2', 'MAPK8', 'TBK1', 'MAPK1', 'MAP3K8', 'BTRC', 'SOS1', 'RAF1', 'MAP3K7', 'MAP3K5', 'NSMAF']",0.230365696738084,0,0,19
43,CAMKK2  Pathway WP4874,0.019602284659035404,2.619832677165354,10.301468055241887,"['RPTOR', 'FIS1', 'CREB1', 'STIM1', 'CAMK4', 'EP300', 'MAPK1', 'ARHGEF7', 'RAF1']",0.230365696738084,0,0,9
44,NLR Proteins WP288,0.019839657767463527,5.815414825724104,22.796847309294904,"['MAPK8', 'CHUK', 'ERBIN', 'MAP3K7']",0.230365696738084,0,0,4
45,Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling WP3850,0.02086114886508566,2.426144756277696,9.388856937315332,"['RPTOR', 'SMAD2', 'GSK3B', 'MSTN', 'RPS6KB1', 'JKAMP', 'PTEN', 'PLD1', 'PPARGC1A', 'PDK1']",0.230365696738084,0,0,10
46,IL-5 signaling pathway WP127,0.02086114886508566,2.426144756277696,9.388856937315332,"['GSK3B', 'STAT5B', 'RPS6KB1', 'RPS6', 'IL5RA', 'MAPK1', 'FOXO3', 'JAK2', 'SOS1', 'RAF1']",0.230365696738084,0,0,10
47,Simplified Interaction Map Between LOXL4 and Oxidative Stress Pathway WP3670,0.02134331710753032,3.4909090909090907,13.429585236996598,"['SUV39H1', 'FN1', 'IGFBP7', 'EXOC6', 'NRF1', 'PKD1']",0.230365696738084,0,0,6
48,Transcription factor regulation in adipogenesis WP3599,0.02134331710753032,3.4909090909090907,13.429585236996598,"['MAPK8', 'CREB1', 'INSR', 'NR3C1', 'PPARGC1A', 'FOXO1']",0.230365696738084,0,0,6
49,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.021500798362221175,2.039220522940306,7.829924100329997,"['GRIA1', 'GSK3B', 'MAP2K4', 'FN1', 'CBL', 'EGFR', 'PTK2', 'MAPK8', 'DAAM1', 'APC', 'MAPK1', 'SOS1', 'RAF1', 'PFN2']",0.230365696738084,0,0,14
50,FTO Obesity Variant Mechanism WP3407,0.025115526657998332,8.720314033366044,32.12798294367867,"['FTO', 'PRDM16', 'PPARGC1A']",0.2637130299089825,0,0,3
51,Splicing factor NOVA regulated synaptic proteins WP4148,0.025894262394468303,2.208782062170885,8.070301818725142,"['KCNJ6', 'PLCB4', 'KCNQ2', 'CASK', 'GRIK2', 'STX2', 'NEO1', 'GRIN2B', 'RAP1GAP', 'GPHN', 'CLASP1']",0.26655858347246786,0,0,11
52,Imatinib and Chronic Myeloid Leukemia WP3640,0.02897838492938941,3.1732856823765916,11.237255360214967,"['BCR', 'ABCB1', 'ABL1', 'GAB2', 'FOXO3', 'SKP2']",0.28924504806124757,0,0,6
53,Hepatitis B infection WP4666,0.0291999762804688,1.6024278301064014,5.6623187610631796,"['PIK3R3', 'PIK3CB', 'MAPK8', 'TBK1', 'EP300', 'MAPK1', 'JAK2', 'MAP3K7', 'SMAD2', 'MAP2K4', 'STAT5B', 'SMAD4', 'CREBBP', 'TICAM2', 'MAP3K1', 'CHUK', 'SLC10A1', 'PRKCA', 'CREB1', 'TRAF3', 'VDAC3', 'RAF1', 'SOS1', 'SOS2', 'TLR4']",0.28924504806124757,0,0,25
54,Biotin Metabolism (including IEMs) WP5031,0.031616522909441405,4.651939126165931,16.068148582469696,"['PC', 'PCCA', 'HLCS', 'ACACA']",0.3043799375541742,0,0,4
55,DNA damage response (only ATM dependent) WP710,0.03188742202948492,1.6896499795624207,5.821762742076854,"['GSK3B', 'SMAD4', 'MAP3K1', 'INSR', 'PIK3R4', 'PTEN', 'PIK3R3', 'PIK3CB', 'PPP2R5C', 'FOXO3', 'MAPK8', 'APC', 'PPP2R5E', 'ABL1', 'MAPK1', 'ATM', 'SOS1', 'MAP3K7', 'SOS2', 'PDK1']",0.3043799375541742,0,0,20
56,Pathways in clear cell renal cell carcinoma WP4018,0.033343841891233135,1.7689335121400338,6.015934449503986,"['SETD2', 'PBRM1', 'CREBBP', 'KSR1', 'PTEN', 'ARNT', 'ACACA', 'EGFR', 'RPTOR', 'ACLY', 'ZEB1', 'EP300', 'ALDOC', 'ENPP3', 'CEP290', 'PSPH', 'PFKP']",0.31259851773031067,0,0,17
57,mBDNF and proBDNF regulation of GABA neurotransmission WP4829,0.03658187177513847,2.277537658336186,7.534555702202159,"['GABRA2', 'GABRB2', 'CREB1', 'ROCK1', 'PTEN', 'PIK3R3', 'PIK3CB', 'JAK2', 'GABRG3']",0.33112901175771886,0,0,9
58,Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway WP2203,0.03658187177513847,2.277537658336186,7.534555702202159,"['STAT5B', 'HCK', 'MAPK8', 'YES1', 'RPS6', 'MAPK1', 'FYN', 'GAB2', 'JAK2']",0.33112901175771886,0,0,9
59,Sleep regulation WP3591,0.041857567803762964,2.5454154375614553,8.07783177081373,"['CACNA1I', 'NLGN1', 'GRIN2A', 'PER3', 'ADORA2A', 'DRD1', 'BTBD9']",0.3552476122854223,0,0,7
60,ERK Pathway in Huntington's Disease WP3853,0.04314078164222157,3.2310085134250164,10.155985504478382,"['CREB1', 'MAPK1', 'RAF1', 'GRM1', 'EGFR']",0.3552476122854223,0,0,5
61,Extracellular vesicles in the crosstalk of cardiac cells WP4300,0.04314078164222157,3.2310085134250164,10.155985504478382,"['PTEN', 'SORBS2', 'PDLIM5', 'TLR4', 'EGFR']",0.3552476122854223,0,0,5
62,TGF-B Signaling in Thyroid Cells for Epithelial-Mesenchymal Transition WP3859,0.04314078164222157,3.2310085134250164,10.155985504478382,"['SMAD2', 'SMAD4', 'FN1', 'MAPK1', 'VIM']",0.3552476122854223,0,0,5
63,Interleukin-11 Signaling Pathway WP2332,0.043578805948343874,2.078849264964479,6.513417980740744,"['YES1', 'CREB1', 'CHUK', 'RPS6KB1', 'RPS6', 'MAPK1', 'FYN', 'JAK2', 'RAF1', 'PIAS1']",0.3552476122854223,0,0,10
64,Disruption of postsynaptic signaling by CNV WP4875,0.043965884149104704,2.182455708661417,6.818736519214524,"['CYFIP1', 'NLGN1', 'GRIN2A', 'NLGN4X', 'MAPK1', 'GRIN2B', 'GRM1', 'YWHAG', 'SHANK1']",0.3552476122854223,0,0,9
65,Insulin signaling in adipocytes (diabetic condition) WP3635,0.044794466785038185,5.813052011776251,18.05342505740065,"['RPS6KB1', 'INSR', 'RPS6']",0.3552476122854223,0,0,3
66,Insulin signaling in adipocytes (normal condition) WP3634,0.044794466785038185,5.813052011776251,18.05342505740065,"['RPS6KB1', 'INSR', 'RPS6']",0.3552476122854223,0,0,3
67,15q13.3 copy number variation syndrome WP4942,0.04668968618608407,3.8762886597938144,11.87784771864111,"['KAT2B', 'CREBBP', 'OTUD7A', 'FYN']",0.3552476122854223,0,0,4
68,miR-509-3p alteration of YAP1/ECM axis WP3967,0.04668968618608407,3.8762886597938144,11.87784771864111,"['SPARC', 'PBX3', 'FN1', 'GPC6']",0.3552476122854223,0,0,4
69,Neuroinflammation WP4919,0.04668968618608407,3.8762886597938144,11.87784771864111,"['MAPK8', 'CHUK', 'ASCC1', 'TLR4']",0.3552476122854223,0,0,4
70,Translation inhibitors in chronically activated PDGFRA cells WP4566,0.049613401218405226,1.9403940886699507,5.827962577098748,"['RPTOR', 'MAP2K4', 'MAPK8', 'RPS6KB1', 'RPS6KA2', 'RPS6', 'PIK3R3', 'MAPK1', 'PRKCA', 'PIK3CB', 'PDK1']",0.3676506348405104,0,0,11
71,Non-small cell lung cancer WP4255,0.04999807117906749,1.694455667789001,5.076200897394041,"['ALK', 'RB1', 'STAT5B', 'PIK3R3', 'PRKCA', 'PIK3CB', 'FOXO3', 'FHIT', 'EGFR', 'EML4', 'RARB', 'MAPK1', 'SOS1', 'RAF1', 'SOS2', 'PDK1']",0.3676506348405104,0,0,16
72,Focal Adhesion WP306,0.050420658492412854,1.4249161217270374,4.2567292993403685,"['GSK3B', 'LAMA5', 'ROCK1', 'PTEN', 'PIK3R3', 'PIK3CB', 'EGFR', 'ARHGAP35', 'MYLK3', 'PPP1CC', 'MAPK8', 'PDGFD', 'MAPK1', 'FLNB', 'FYN', 'PAK3', 'PPP1R12A', 'ACTN1', 'STYK1', 'FN1', 'VEGFB', 'PRKCA', 'PARVA', 'VEGFD', 'PTK2', 'HCK', 'DIAPH1', 'COL4A2', 'ITGA8', 'RAF1', 'PPP1R12B', 'SOS1']",0.3676506348405104,0,0,32
73,3q29 copy number variation syndrome WP4906,0.052211411538008685,1.8021978021978022,5.320906463384691,"['GRIA1', 'STAT5B', 'FBXW7', 'DYNLT3', 'MYCBP2', 'ADAM10', 'PIK3R3', 'RABL2B', 'DYNLL1', 'TF', 'BRINP1', 'WDR60', 'NF2']",0.37359739331612307,0,0,13
74,PDGFR-beta pathway WP3972,0.05265944210551068,2.216569461035767,6.525380379723699,"['STAT5B', 'MAP2K4', 'MAPK8', 'MAP3K1', 'PRKCA', 'JAK2', 'SOS1', 'RAF1']",0.37359739331612307,0,0,8
75,MAPK pathway in congenital thyroid cancer WP4928,0.05711517593055058,2.907662082514735,8.323721848490669,"['ALK', 'KSR1', 'RAF1', 'SOS1', 'SOS2']",0.39454562320446124,0,0,5
76,MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement WP4560,0.05711517593055058,2.907662082514735,8.323721848490669,"['CREB1', 'ACTN1', 'MAPK1', 'LPP', 'PTK2']",0.39454562320446124,0,0,5
77,MET in type 1 papillary renal cell carcinoma WP4205,0.0592164824612605,1.7601371496720335,4.975125087506612,"['ALK', 'PIK3R3', 'PIK3CB', 'CBL', 'PTK2', 'MAPK8', 'ELOA', 'MAPK1', 'SOS1', 'RAF1', 'PAK3', 'SOS2', 'PAK5']",0.40374874405404887,0,0,13
78,Netrin-UNC5B signaling pathway WP4747,0.06156559462839048,2.0142337976983646,5.614983062424267,"['DAPK1', 'MAPK1', 'PRKCA', 'FYN', 'RAF1', 'NEO1', 'RLF', 'PTK2', 'RGMA']",0.4143838099987821,0,0,9
79,Notch Signaling Pathway Netpath WP61,0.06245757908897765,1.7911058877051977,4.9672160828352725,"['NCOR2', 'SPEN', 'GSK3B', 'ITCH', 'NCOR1', 'FBXW7', 'HDAC1', 'NUMB', 'CUL1', 'EP300', 'MAML3', 'JAK2']",0.4150661901482692,0,0,12
80,Leptin Insulin Overlap WP3935,0.06506286550686413,3.32225261238516,9.077727406318203,"['SOCS2', 'INSR', 'PIK3R3', 'JAK2']",0.42170375791486014,0,0,4
81,MAPK and NFkB signaling pathways inhibited by Yersinia YopJ WP3849,0.06506286550686413,3.32225261238516,9.077727406318203,"['MAP3K1', 'CHUK', 'MAPK1', 'RAF1']",0.42170375791486014,0,0,4
82,Acute viral myocarditis WP4298,0.06682514655947773,1.719988344988345,4.653730882211811,"['GSK3B', 'ENDOG', 'SGCD', 'CREB1', 'CASP6', 'JKAMP', 'ABL1', 'CASP2', 'MAPK1', 'ABL2', 'FYN', 'SOS1', 'TLR4']",0.42640839666771024,0,0,13
83,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.06763160120576943,1.472772519848833,3.9671777806860082,"['SMAD2', 'MAP2K4', 'GSK3B', 'SMAD4', 'SPARC', 'TUSC3', 'EED', 'NUBPL', 'FN1', 'PIK3R3', 'PIK3CB', 'NR2C2', 'CLDN1', 'PKD1', 'LRP6', 'ZEB2', 'MAPK8', 'ZEB1', 'COL4A2', 'MAPK1', 'RAF1', 'SOS1', 'SOS2']",0.42640839666771024,0,0,23
84,G13 Signaling Pathway WP524,0.07183327855832305,1.9394685039370079,5.107410750357285,"['GNA13', 'CYFIP1', 'DIAPH1', 'ROCK1', 'RPS6KB1', 'ARHGDIG', 'PIP4K2A', 'PIK3CB', 'PAK3']",0.42640839666771024,0,0,9
85,Glycogen Synthesis and Degradation WP500,0.07183327855832305,1.9394685039370079,5.107410750357285,"['GYS2', 'GSK3B', 'PHKG1', 'PPP2R5E', 'AGL', 'PHKB', 'PPP2R5C', 'GYG1', 'PHKA2']",0.42640839666771024,0,0,9
86,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.07327695601706798,1.4566402378592667,3.806942514955484,"['CREBBP', 'HDAC1', 'SLC1A3', 'AQP4', 'RORA', 'NR3C1', 'PBX1', 'GJA1', 'TF', 'CREB1', 'DEAF1', 'MAP2', 'PRKAR2B', 'SP1', 'PRKAR2A', 'SP3', 'EP300', 'PPARGC1A', 'SCN4B', 'SPTBN1', 'CC2D1A', 'YWHAG', 'YWHAH']",0.42640839666771024,0,0,23
87,"4-hydroxytamoxifen, Dexamethasone, and Retinoic Acids Regulation of p27 Expression WP3879",0.07337512565043264,2.643105911769959,6.904242731802252,"['PRKAA1', 'MKNK1', 'MAPK1', 'RAF1', 'MAP3K5']",0.42640839666771024,0,0,5
88,Kynurenine Pathway and links to Cellular Senescence WP5044,0.07337512565043264,2.643105911769959,6.904242731802252,"['HAAO', 'AHR', 'EIF2AK4', 'TLR4', 'FOXO1']",0.42640839666771024,0,0,5
89,Nanoparticle-mediated activation of receptor signaling WP2643,0.07599194792834375,2.1429643430109198,5.522693181263516,"['MAPK8', 'FN1', 'MAPK1', 'SOS1', 'RAF1', 'EGFR', 'PTK2']",0.42640839666771024,0,0,7
90,Gastric Cancer Network 1 WP2361,0.0761101037864585,2.326289926289926,5.991532439319501,"['NUP107', 'APC', 'ACTL6A', 'CEP192', 'GATD3B', 'KIF15']",0.42640839666771024,0,0,6
91,Hypothesized Pathways in Pathogenesis of Cardiovascular Disease WP3668,0.0761101037864585,2.326289926289926,5.991532439319501,"['FBN2', 'SMAD2', 'MAPK8', 'SMAD4', 'MAPK1', 'NR2C2']",0.42640839666771024,0,0,6
92,NRF2-ARE regulation WP4357,0.0761101037864585,2.326289926289926,5.991532439319501,"['GSK3B', 'MAPK8', 'YES1', 'INSR', 'PRKCA', 'FYN']",0.42640839666771024,0,0,6
93,Toll-like Receptor Signaling related to MyD88 WP3858,0.0761101037864585,2.326289926289926,5.991532439319501,"['TBK1', 'TICAM2', 'CHUK', 'TRAF3', 'MAPK1', 'TLR4']",0.42640839666771024,0,0,6
94,Ebola Virus Pathway on Host WP4217,0.07634740816526622,1.49354850987706,3.8420955839839226,"['CREBBP', 'TSG101', 'GSN', 'ACTN1', 'DAB2IP', 'PIK3R3', 'PIK3CB', 'MERTK', 'EGFR', 'TIAM1', 'TBK1', 'RASA2', 'TYRO3', 'EP300', 'HLA-DRA', 'MAPK1', 'FLNB', 'TOP1', 'TLR4', 'KPNA1']",0.42640839666771024,0,0,20
95,Copper homeostasis WP3286,0.0830984615413671,1.8700435883014623,4.652161835369378,"['GSK3B', 'ATP7B', 'APC', 'SP1', 'COX17', 'PTEN', 'ADAM10', 'FOXO3', 'FOXO1']",0.4523893723652351,0,0,9
96,Regulation of Wnt/B-catenin Signaling by Small Molecule Compounds WP3664,0.08661843507912585,2.9067255768286695,7.110555961226474,"['GSK3B', 'SFRP4', 'APC', 'TNKS']",0.4523893723652351,0,0,4
97,Mitochondrial CIV Assembly WP4922,0.08691889022274539,1.9390063944909002,4.736565829906374,"['COX8A', 'COX17', 'CMC1', 'COX6A1', 'HIGD1A', 'COX5B', 'COX10', 'COX20']",0.4523893723652351,0,0,8
98,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.09004424136350866,1.7631260910433733,4.244645240243364,"['PPP1R16B', 'PPP1CC', 'PPP1R14A', 'MAPK8', 'PPP1R13B', 'PPP1R12A', 'PPP1R3D', 'PPP1R9A', 'PPP1R12B', 'ATF6']",0.4523893723652351,0,0,10
99,Envelope proteins and their potential roles in EDMD physiopathology WP4535,0.09004424136350866,1.7631260910433733,4.244645240243364,"['SMAD2', 'SMAD4', 'SUN1', 'ADCY9', 'MAPK1', 'MAP3K9', 'SOS1', 'SOS2', 'SYNE1', 'ADCY5']",0.4523893723652351,0,0,10
100,IL17 signaling pathway WP2112,0.09015523161479026,2.035644051130777,4.898212108014207,"['GSK3B', 'TRAF3', 'SP1', 'MAPK1', 'JAK2', 'MAP3K7', 'IL17RC']",0.4523893723652351,0,0,7
101,Regucalcin in proximal tubule epithelial kidney cells WP4838,0.09015523161479026,2.035644051130777,4.898212108014207,"['SMAD2', 'ACTA2', 'SEC16B', 'SMAD4', 'MAPK1', 'RAF1', 'MAP3K5']",0.4523893723652351,0,0,7
102,Constitutive Androstane Receptor Pathway WP2875,0.09187378013388504,2.4226424361493124,5.7836702220167195,"['ABCB1', 'NCOA6', 'SP1', 'PPARGC1A', 'FOXO1']",0.4523893723652351,0,0,5
103,Ebstein-Barr virus LMP1 signaling WP262,0.09187378013388504,2.4226424361493124,5.7836702220167195,"['MAPK8', 'CHUK', 'MAPK1', 'MAP3K7', 'PDLIM7']",0.4523893723652351,0,0,5
104,Nuclear Receptors in Lipid Metabolism and Toxicity WP299,0.09187378013388504,2.4226424361493124,5.7836702220167195,"['ABCA1', 'ABCB1', 'ABCD3', 'RARB', 'PPARA']",0.4523893723652351,0,0,5
105,Proteoglycan biosynthesis WP4784,0.09187378013388504,2.4226424361493124,5.7836702220167195,"['EXT1', 'EXT2', 'CHSY1', 'XYLT1', 'PAPSS2']",0.4523893723652351,0,0,5
106,EPO Receptor Signaling WP581,0.09220126255824791,2.1807125307125306,5.198342089012711,"['STAT5B', 'MAPK1', 'JAK2', 'SOS1', 'RAF1', 'PDK1']",0.4523893723652351,0,0,6
107,Nanoparticle triggered autophagic cell death WP2509,0.09220126255824791,2.1807125307125306,5.198342089012711,"['VMP1', 'UVRAG', 'INSR', 'ATG10', 'AMBRA1', 'ATG5']",0.4523893723652351,0,0,6
108,Alzheimer's disease WP2059,0.09897294194992785,1.531797163194264,3.5429071076884977,"['GSK3B', 'ADAM10', 'IDE', 'CACNA1C', 'GRIN2B', 'VMP1', 'GRIN2A', 'PPP3CC', 'PLCB4', 'PPP3R2', 'GNAQ', 'MAPK1', 'APOE', 'ATF6', 'CDK5R1']",0.47611284440687024,0,0,15
109,p38 MAPK Signaling Pathway WP400,0.10066385853173827,1.8612887358583374,4.27346020650888,"['MAP2K4', 'MAP3K1', 'CREB1', 'MKNK1', 'MAPKAPK2', 'MAP3K9', 'MAP3K7', 'MAP3K5']",0.47611284440687024,0,0,8
110,TNF related weak inducer of apoptosis (TWEAK) Signaling Pathway WP2036,0.10066385853173827,1.8612887358583374,4.27346020650888,"['GSK3B', 'MAPK8', 'CHUK', 'HDAC1', 'TRAF3', 'MAPK1', 'RAF1', 'MAP3K7']",0.47611284440687024,0,0,8
111,Type 2 papillary renal cell carcinoma WP4241,0.10066385853173827,1.8612887358583374,4.27346020650888,"['EGLN1', 'DIAPH1', 'SETD2', 'EGLN3', 'CREBBP', 'TFEB', 'EP300', 'ARNT']",0.47611284440687024,0,0,8
112,Sulindac Metabolic Pathway WP2542,0.1055262006598851,5.81069151544875,13.067059891865814,"['MSRA', 'MSRB3']",0.49365569629292044,0,0,2
113,Calcium Regulation in the Cardiac Cell WP536,0.10625351177352382,1.3704686634197556,3.0724912744120396,"['RYR1', 'PRKCE', 'CACNA1B', 'GNAI3', 'PRKCA', 'ATP2B2', 'CACNA1C', 'SLC8A1', 'ADCY5', 'PKIB', 'GJA1', 'ADCY9', 'GJC2', 'PLN', 'GRK5', 'PRKAR2B', 'GRK4', 'PRKAR2A', 'GNAQ', 'CAMK4', 'ANXA6', 'RGS9', 'YWHAG', 'YWHAH']",0.49365569629292044,0,0,24
114,Cannabinoid receptor signaling WP3869,0.10996963405057344,2.0522618875560052,4.5304727931883155,"['FAAH', 'MAPK8', 'ADORA2A', 'PRKAR2B', 'MAPK1', 'AHR']",0.4972442785804166,0,0,6
115,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.1102037735680683,1.4782833627278071,3.2602418138392233,"['GSK3B', 'RPS6', 'PTEN', 'PIK3R3', 'PRKCA', 'PIK3CB', 'NRG2', 'FOXO3', 'EGFR', 'RPS6KB1', 'PDGFD', 'MAPK1', 'JAK2', 'SOS1', 'RAF1', 'SOS2']",0.4972442785804166,0,0,16
116,Airway smooth muscle cell contraction WP4962,0.11114096611914001,2.583537882506955,5.675918841270622,"['RYR1', 'PPP1R14A', 'ROCK1', 'GNAQ']",0.4972442785804166,0,0,4
117,Type II diabetes mellitus WP1584,0.11114096611914001,2.583537882506955,5.675918841270622,"['MAPK8', 'INSR', 'MAPK1', 'PHKA2']",0.4972442785804166,0,0,4
118,miRNAs involvement in the immune response in sepsis WP4329,0.11251438871420202,2.236096418316458,4.885142077410649,"['MAPK8', 'CHUK', 'TRAF3', 'MAP3K7', 'TLR4']",0.4972442785804166,0,0,5
119,Integrated breast cancer pathway WP1984,0.11330186416332212,1.3482418430335097,2.9360658001307702,"['RB1', 'RALA', 'USP15', 'BMPR2', 'USP38', 'HDAC1', 'NAB1', 'MYCBP2', 'PTEN', 'AHR', 'JAKMIP1', 'FOXO1', 'EGFR', 'RASGEF1A', 'ABL1', 'EP300', 'MAPK1', 'SMAD2', 'SMAD4', 'CHUK', 'PIAS1', 'CREB1', 'SP1', 'ATM', 'BMPR1A']",0.4972442785804166,0,0,25
120,Fas ligand pathway and stress induction of heat shock proteins WP314,0.11555009902249681,1.7895493586590487,3.861938935643956,"['RB1', 'MAP2K4', 'MAPK8', 'MAP3K1', 'CASP6', 'FAF1', 'MAPKAPK2', 'MAP3K7']",0.4972442785804166,0,0,8
121,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.11555009902249681,1.7895493586590487,3.861938935643956,"['MAP2K4', 'MAPK8', 'MAP3K1', 'RPS6KA2', 'MAPK1', 'MAP3K10', 'MAP3K9', 'RAF1']",0.4972442785804166,0,0,8
122,Vitamin D-sensitive calcium signaling in depression WP4698,0.11555009902249681,1.7895493586590487,3.861938935643956,"['GRIN2A', 'CALB1', 'KCNQ2', 'KCNQ3', 'ATP2B2', 'CACNA1C', 'GRIN2B', 'SLC8A1']",0.4972442785804166,0,0,8
123,Initiation of transcription and translation elongation at the HIV-1 LTR WP3414,0.12256807947418473,1.8502726378832572,3.883886298322953,"['CREBBP', 'PPP3CC', 'PPP3R2', 'HDAC1', 'SP1', 'EP300', 'NELFA']",0.5189374332576369,0,0,7
124,Melatonin metabolism and effects WP3298,0.12256807947418473,1.8502726378832572,3.883886298322953,"['GSK3B', 'PER3', 'MAP2', 'PRKCA', 'APOE', 'CLOCK', 'FOXO1']",0.5189374332576369,0,0,7
125,Thermogenesis WP4321,0.13117884382465583,1.3969352446861096,2.837446021951511,"['PRKAA1', 'SMARCD3', 'RPS6', 'ACTL6A', 'ACSL4', 'CPT1C', 'ADCY5', 'RPTOR', 'ADCY9', 'CREB1', 'RPS6KB1', 'RPS6KA2', 'PRDM16', 'ZNF516', 'SOS1', 'PPARGC1A', 'SOS2', 'MAP3K5']",0.5425794944687987,0,0,18
126,Farnesoid X receptor pathway WP2879,0.13428876269813547,2.9057899901864572,5.834137198264075,"['SLC10A1', 'PPARGC1A', 'FKBP5']",0.5425794944687987,0,0,3
127,Ras signaling WP4223,0.13451810801251007,1.2995108619826503,2.606892155542732,"['RALA', 'PIK3R3', 'PIK3CB', 'RASGRP2', 'PLD1', 'EGFR', 'GRIN2A', 'MAPK8', 'ABL1', 'ABL2', 'MAPK1', 'SHOC2', 'PAK3', 'PAK5', 'KSR1', 'CHUK', 'INSR', 'PRKCA', 'KSR2', 'GAB2', 'GRIN2B', 'TIAM1', 'RASA2', 'RAF1', 'SOS1', 'SOS2', 'ARF6']",0.5425794944687987,0,0,27
128,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.13515761697411366,2.0761998316025823,4.1551270598728065,"['KDM2B', 'H2AFJ', 'H2AFZ', 'EED', 'MAPK1']",0.5425794944687987,0,0,5
129,Hereditary leiomyomatosis and renal cell carcinoma pathway WP4206,0.13515761697411366,2.0761998316025823,4.1551270598728065,"['EGLN1', 'PRKAA1', 'RPS6', 'ACACA', 'PDK1']",0.5425794944687987,0,0,5
130,Serotonin Receptor 4/6/7 and NR3C Signaling WP734,0.13515761697411366,2.0761998316025823,4.1551270598728065,"['CREB1', 'MAPKAPK2', 'MAPK1', 'HTR4', 'NR3C1']",0.5425794944687987,0,0,5
131,Arrhythmogenic Right Ventricular Cardiomyopathy WP2118,0.13538650242935737,1.5176463025264104,3.034718343035277,"['CACNB2', 'CACNG7', 'GJA1', 'SGCD', 'ACTN1', 'ITGA8', 'CACNA2D2', 'CACNA1C', 'CTNNA2', 'CACNG2', 'SLC8A1', 'CACNG4']",0.5425794944687987,0,0,12
132,Transcription co-factors SKI and SKIL protein partners WP4533,0.13834105192960855,2.324987727049583,4.598903034351014,"['LATS1', 'HDAC1', 'SATB2', 'MERTK']",0.5448355368367331,0,0,4
133,Kisspeptin/kisspeptin receptor system in the ovary WP4871,0.1407226792111484,1.769676371253901,3.4702719024220112,"['PLCB4', 'PRKCE', 'MAPK1', 'PRKCA', 'PIK3CB', 'RAF1', 'PDK1']",0.5448355368367331,0,0,7
134,miRNA regulation of prostate cancer signaling pathways WP3981,0.1407226792111484,1.769676371253901,3.4702719024220112,"['GSK3B', 'CREBBP', 'PLCL2', 'MAPK1', 'SOS1', 'RAF1', 'FOXO1']",0.5448355368367331,0,0,7
135,Pancreatic adenocarcinoma pathway WP4263,0.140839170769433,1.410729517396184,2.765222661972319,"['RB1', 'SMAD2', 'RALA', 'SMAD4', 'CHUK', 'PIK3R3', 'PIK3CB', 'PLD1', 'EGFR', 'TIAM1', 'MAPK8', 'RPS6KB1', 'MAPK1', 'RAF1', 'PAK3', 'PAK5']",0.5448355368367331,0,0,16
136,Wnt signaling WP428,0.14113834859008706,1.3934406836274564,2.7283773058736207,"['INVS', 'GSK3B', 'PRICKLE2', 'PRKCA', 'PRICKLE1', 'NLK', 'CXXC4', 'LRP6', 'SFRP4', 'MAPK8', 'PPP3R2', 'PPP3CC', 'PLCB4', 'DAAM1', 'APC', 'NOTUM', 'MAP3K7']",0.5448355368367331,0,0,17
137,Wnt Signaling Pathway WP363,0.14273381718589306,1.5719855749397846,3.0603003337773558,"['GSK3B', 'GJA1', 'MAPK8', 'APC', 'MAPK1', 'PRKCA', 'NLK', 'MAP3K7', 'CSNK1G1', 'LRP6']",0.5469726570992253,0,0,10
138,Genes related to primary cilium development (based on CRISPR) WP4536,0.15100628957974987,1.3485320016404911,2.549310463051911,"['TTC26', 'IFT140', 'IFT172', 'CEP120', 'ARMC9', 'SCLT1', 'IFT122', 'CPLANE1', 'RPGRIP1L', 'DYNLL1', 'TTBK2', 'IFT88', 'WDR60', 'TMEM67', 'INPP5E', 'SASS6', 'CEP192', 'CEP97', 'PIBF1']",0.571735230496907,0,0,19
139,Hippo-Merlin Signaling Dysregulation WP4541,0.15190961182987772,1.3739706851119895,2.58920597918159,"['PPP1R14A', 'PPP1R12A', 'INSR', 'PTK2', 'EGFR', 'DCAF1', 'LATS1', 'CUL4A', 'PPP1CC', 'PLCB4', 'CDH20', 'PRKAR2B', 'PRKAR2A', 'ITGA8', 'NF2', 'PAK3', 'PAK5']",0.571735230496907,0,0,17
140,Pathogenic Escherichia coli infection WP2272,0.15796824556132913,1.5304879628909793,2.824303170536431,"['TUBB6', 'ROCK1', 'ARPC5L', 'NCK2', 'ABL1', 'PRKCA', 'FYN', 'EZR', 'CLDN1', 'TLR4']",0.571735230496907,0,0,10
141,Rett syndrome causing genes WP4312,0.15796824556132913,1.5304879628909793,2.824303170536431,"['NCOR2', 'KDM5B', 'SRRM3', 'GRIN2A', 'NCOR1', 'TRRAP', 'HDAC1', 'TBL1XR1', 'SATB2', 'GRIN2B']",0.571735230496907,0,0,10
142,Eicosanoid metabolism via cytochrome P450 monooxygenases (CYP) pathway WP4720,0.15913334774033788,3.8734673859735165,7.1194824933022245,"['PPARA', 'CYP2C18']",0.571735230496907,0,0,2
143,Somatroph axis (GH) and its relationship to dietary restriction and aging WP4186,0.15913334774033788,3.8734673859735165,7.1194824933022245,"['PTEN', 'FOXO1']",0.571735230496907,0,0,2
144,TCA Cycle Nutrient Utilization and Invasiveness of Ovarian Cancer WP2868,0.15913334774033788,3.8734673859735165,7.1194824933022245,"['MAPK1', 'EGFR']",0.571735230496907,0,0,2
145,T-Cell Receptor and Co-stimulatory Signaling WP2583,0.15962945878146498,1.93762278978389,3.555344119303466,"['GSK3B', 'PTEN', 'FYN', 'PRKCA', 'PDK1']",0.571735230496907,0,0,5
146,MAPK Cascade WP422,0.16008586453913395,1.6957964601769913,3.1067753484305465,"['MAP2K4', 'MAP3K1', 'MAP2', 'MAPK1', 'SOS1', 'RAF1', 'SOS2']",0.571735230496907,0,0,7
147,Neural Crest Cell Migration in Cancer WP4565,0.16008586453913395,1.6957964601769913,3.1067753484305465,"['TIAM1', 'KIDINS220', 'PIK3R4', 'PIK3R3', 'PIK3CB', 'PAK3', 'PAK5']",0.571735230496907,0,0,7
148,IL-18 signaling pathway WP4754,0.16563503754847766,1.234075797981929,2.218829386716822,"['GSK3B', 'SPON1', 'PRKAA1', 'STOML1', 'COX17', 'PTEN', 'PLD1', 'CLDN1', 'RPTOR', 'NFKBIZ', 'MAPK1', 'TRPM7', 'MAP3K7', 'MEF2A', 'ZNF143', 'TICAM2', 'USP5', 'CHUK', 'FBXW7', 'SEMA6D', 'FN1', 'PRKCA', 'EEF2', 'GRIN2B', 'IL17RC', 'ACTA2', 'TF', 'ALS2', 'RPS6KB1', 'SP1', 'KIFC3', 'ARF6']",0.5798408882939895,0,0,32
149,Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms WP4534,0.16667724677349413,1.6040164865919229,2.873909907886096,"['LATS1', 'ACTA2', 'MAPK8', 'SGMS1', 'NF2', 'PAK3', 'PAK5', 'MAP4K4']",0.5798408882939895,0,0,8
150,Interactome of polycomb repressive complex 2 (PRC2)  WP2916,0.16787774289654553,2.1134466907662786,3.7714863782318284,"['MORC3', 'EED', 'STK38', 'JARID2']",0.5798408882939895,0,0,4
151,MAP3K1 role in promoting and blocking gonadal determination WP4872,0.16787774289654553,2.1134466907662786,3.7714863782318284,"['GSK3B', 'MAP3K1', 'ROCK1', 'MAPK1']",0.5798408882939895,0,0,4
152,SREBF and miR33 in cholesterol and lipid homeostasis WP2011,0.16787774289654553,2.1134466907662786,3.7714863782318284,"['ABCA1', 'PRKAA1', 'PPARA', 'PPARGC1A']",0.5798408882939895,0,0,4
153,"GPCRs, Class C Metabotropic glutamate, pheromone WP501",0.17183123717995366,2.4904668442450584,4.3863159588437375,"['GPRC5B', 'GRM8', 'GRM1']",0.5835295472800923,0,0,3
154,MFAP5-mediated ovarian cancer cell motility and invasiveness WP3301,0.17183123717995366,2.4904668442450584,4.3863159588437375,"['CREB1', 'MAPK1', 'PTK2']",0.5835295472800923,0,0,3
155,Cardiac Hypertrophic Response WP2795,0.17396736467304508,1.4911184335113434,2.6077984739479687,"['MEF2A', 'GSK3B', 'MAP2K4', 'MAPK8', 'MAP3K1', 'CHUK', 'MAPK1', 'PRKCA', 'RAF1', 'MAP3K7']",0.5835295472800923,0,0,10
156,Senescence and Autophagy in Cancer WP615,0.1764996679707036,1.3634470631786773,2.3648120574127,"['RB1', 'UVRAG', 'GSK3B', 'SMAD4', 'SPARC', 'GSN', 'KMT2A', 'ATG10', 'FN1', 'PTEN', 'AMBRA1', 'MAPK1', 'IGFBP7', 'RAF1', 'ATG5']",0.5835295472800923,0,0,15
157,Spinal Cord Injury WP2431,0.1764996679707036,1.3634470631786773,2.3648120574127,"['RB1', 'EPHA4', 'XYLT1', 'AQP4', 'PRKCA', 'FOXO3', 'EGFR', 'GFAP', 'RGMA', 'ACAN', 'GJA1', 'PRB1', 'MAPK1', 'VIM', 'TLR4']",0.5835295472800923,0,0,15
158,Endometrial cancer WP4155,0.17672609146197082,1.4243670854246084,2.4686478689411806,"['GSK3B', 'APC', 'PTEN', 'PIK3R3', 'MAPK1', 'PIK3CB', 'CTNNA2', 'SOS1', 'RAF1', 'FOXO3', 'SOS2', 'EGFR']",0.5835295472800923,0,0,12
159,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.17672609146197082,1.4243670854246084,2.4686478689411806,"['RB1', 'GNA13', 'CREB1', 'RPS6KB1', 'GNAQ', 'RPS6', 'GNAI3', 'MAPK1', 'JAK2', 'RAF1', 'PLD1', 'RAP1GAP']",0.5835295472800923,0,0,12
160,VEGFA-VEGFR2 Signaling Pathway WP3888,0.18296760224936495,1.147236459010082,1.9485193798736455,"['GSK3B', 'FAF1', 'ARPC5L', 'SLC8A1', 'RPL7', 'GJA1', 'ELOA', 'RPLP2', 'LRRFIP2', 'MAP3K5', 'TMOD1', 'ACOT9', 'MAP2K4', 'FBXW11', 'PRKCE', 'SEMA6D', 'TRPC1', 'RPS6', 'ARNT', 'ADAM10', 'PRKCA', 'PGD', 'CREB1', 'EWSR1', 'MAPKAPK2', 'NUMB', 'RPL27', 'RPL26', 'EZR', 'RAF1', 'ATF6', 'ARF6', 'PRKAA1', 'ROCK1', 'HDAC1', 'FOXO3', 'CBL', 'GIGYF2', 'FOXO1', 'ACACA', 'MAPK8', 'MKNK1', 'MYO6', 'FAM120A', 'ABL1', 'MAPK1', 'FLNB', 'IGFBP7', 'FYN', 'BRD4', 'PTPN1', 'RBM39', 'CREBBP', 'FN1', 'PRRC2C', 'PDE4DIP', 'PTK2', 'SRPK1', 'ITCH', 'RPS6KB1', 'SPIRE1', 'PTPN9']",0.590202832961699,0,0,62
161,Aryl Hydrocarbon Receptor Netpath WP2586,0.1856943316873432,1.5504181013280867,2.6103666071328213,"['RB1', 'NCOR2', 'EP300', 'MAPK1', 'ARNT', 'AHR', 'RAF1', 'EGFR']",0.590202832961699,0,0,8
162,PDGF Pathway WP2526,0.1856943316873432,1.5504181013280867,2.6103666071328213,"['MAP2K4', 'TIAM1', 'MAPK8', 'MAP3K1', 'CHUK', 'MAPK1', 'SOS1', 'RAF1']",0.590202832961699,0,0,8
163,Angiogenesis WP1539,0.18572926216481658,1.8163678781925343,3.0577921958222523,"['CREBBP', 'ANGPT1', 'ARNT', 'MAPK1', 'PTK2']",0.590202832961699,0,0,5
164,Heart Development WP1591,0.18572926216481658,1.8163678781925343,3.0577921958222523,"['SMAD4', 'BMPR2', 'VEGFB', 'MAPK1', 'BMPR1A']",0.590202832961699,0,0,5
165,TLR4 Signaling and Tolerance WP3851,0.18572926216481658,1.8163678781925343,3.0577921958222523,"['TBK1', 'CHUK', 'TRAF3', 'MAP3K7', 'TLR4']",0.590202832961699,0,0,5
166,IL-4 signaling pathway WP395,0.18886490654774366,1.4951490438695163,2.491999747897101,"['STAT5B', 'CHUK', 'RPS6KB1', 'EP300', 'MAPK1', 'GAB2', 'JAK2', 'SOS1', 'CBL']",0.590202832961699,0,0,9
167,RANKL/RANK signaling pathway WP2018,0.18886490654774366,1.4951490438695163,2.491999747897101,"['MAPK8', 'CHUK', 'TRAF3', 'MAPK1', 'GAB2', 'CBL', 'MAP3K7', 'PAPSS2', 'PTK2']",0.590202832961699,0,0,9
168,T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection WP3863,0.18886490654774366,1.4951490438695163,2.491999747897101,"['GSK3B', 'CHUK', 'MAP3K8', 'FYN', 'SOS1', 'RAF1', 'CBL', 'MAP3K7', 'PDK1']",0.590202832961699,0,0,9
169,Toll-like Receptor Signaling Pathway WP75,0.1917232445986962,1.3957614588467224,2.305382525167207,"['MAP2K4', 'MAPK8', 'TBK1', 'TICAM2', 'CHUK', 'TRAF3', 'PIK3R3', 'MAPK1', 'MAP3K8', 'PIK3CB', 'MAP3K7', 'TLR4']",0.5955899610314527,0,0,12
170,Intraflagellar transport proteins binding to dynein WP4532,0.19601459498738816,1.6607932607932607,2.706372493725679,"['IFT140', 'WDR60', 'DYNLT3', 'IFT122', 'DYNLL1', 'DYNC1I1']",0.6053391904022282,0,0,6
171,Parkinson's disease pathway WP2371,0.2020865203894766,1.565085848271689,2.502665166311102,"['PRKN', 'ATXN2', 'GPR37', 'CASP6', 'CASP2', 'UBE2G1', 'PARK7']",0.6072672255687076,0,0,7
172,Corticotropin-releasing hormone signaling pathway WP2355,0.20472755638391152,1.334816048913439,2.1171186010263825,"['GSK3B', 'PRKCA', 'ACACA', 'PTK2', 'GJA1', 'GRK3', 'MAPK8', 'CREB1', 'SP1', 'GNAQ', 'MAPK1', 'RAF1', 'TLR4', 'MAP3K5']",0.6072672255687076,0,0,14
173,MAPK Signaling Pathway WP382,0.20720077337696063,1.1846147603700525,1.8646630447635455,"['CACNA1B', 'CACNA1C', 'NLK', 'RASGRP2', 'EGFR', 'CACNA1I', 'CACNG7', 'MAPK8', 'PPP3R2', 'PPP3CC', 'MKNK1', 'MAPK1', 'FLNB', 'MAP3K8', 'CACNG2', 'MAP3K7', 'CACNG4', 'MAP4K4', 'MAP3K5', 'MAP2K4', 'MAP3K1', 'CHUK', 'CACNA2D2', 'PRKCA', 'MAPK8IP3', 'CACNB2', 'PPM1B', 'FGF14', 'TAOK3', 'TAOK1', 'MAPKAPK2', 'RASA2', 'RAF1', 'SOS1', 'SOS2']",0.6072672255687076,0,0,35
174,Structural Pathway of Interleukin 1 (IL-1) WP2637,0.20740807731924735,1.453494094488189,2.286443650455919,"['MAP2K4', 'MAPK8', 'MAP3K1', 'CHUK', 'MKNK1', 'MAPKAPK2', 'MAPK1', 'MAP3K8', 'MAP3K7']",0.6072672255687076,0,0,9
175,Bone morphogenic protein (BMP) signaling and regulation WP1425,0.21186938372166372,2.1789744847890087,3.381300593543259,"['SMAD4', 'BMPR2', 'BMPR1A']",0.6072672255687076,0,0,3
176,Glycolysis in senescence WP5049,0.21186938372166372,2.1789744847890087,3.381300593543259,"['RB1', 'PRKAA1', 'ALDOC']",0.6072672255687076,0,0,3
177,Homologous recombination WP186,0.21186938372166372,2.1789744847890087,3.381300593543259,"['POLD4', 'ATM', 'RAD54B']",0.6072672255687076,0,0,3
178,Inflammatory Response Pathway WP453,0.21186938372166372,2.1789744847890087,3.381300593543259,"['LAMA5', 'FN1', 'IL5RA']",0.6072672255687076,0,0,3
179,Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4) WP2817,0.21323750020449173,1.7093782503178088,2.6415854740589104,"['PTPN1', 'CHUK', 'NR3C1', 'JAK2', 'EGFR']",0.6072672255687076,0,0,5
180,MTHFR deficiency WP4288,0.21323750020449173,1.7093782503178088,2.6415854740589104,"['GRIN2A', 'SGMS1', 'CHDH', 'DNMT3A', 'EHMT1']",0.6072672255687076,0,0,5
181,ApoE and miR-146 in inflammation and atherosclerosis WP3926,0.21630280225018728,2.9048553212359,4.447554238859928,"['APOE', 'TLR4']",0.6072672255687076,0,0,2
182,Cellular Proteostasis WP4918,0.21630280225018728,2.9048553212359,4.447554238859928,"['PFDN5', 'PFDN6']",0.6072672255687076,0,0,2
183,Drug Induction of Bile Acid Pathway WP2289,0.21630280225018728,2.9048553212359,4.447554238859928,"['ABCB1', 'SLC10A1']",0.6072672255687076,0,0,2
184,exRNA mechanism of action and biogenesis WP2805,0.21630280225018728,2.9048553212359,4.447554238859928,"['DROSHA', 'DICER1']",0.6072672255687076,0,0,2
185,miRNA Biogenesis WP2338,0.21630280225018728,2.9048553212359,4.447554238859928,"['DROSHA', 'DICER1']",0.6072672255687076,0,0,2
186,Molybdenum cofactor (Moco) biosynthesis WP4507,0.21630280225018728,2.9048553212359,4.447554238859928,"['MARC2', 'GPHN']",0.6072672255687076,0,0,2
187,Pilocytic astrocytoma WP2253,0.21630280225018728,2.9048553212359,4.447554238859928,"['SOS1', 'RAF1']",0.6072672255687076,0,0,2
188,Autophagy WP4923,0.2206476018416925,1.5851686397140943,2.395488479296215,"['RPTOR', 'UVRAG', 'PRKAA1', 'PIK3R4', 'AMBRA1', 'ATG5']",0.6129100051158125,0,0,6
189,Neural Crest Cell Migration during Development WP4564,0.2206476018416925,1.5851686397140943,2.395488479296215,"['TIAM1', 'PIK3R4', 'PIK3R3', 'PIK3CB', 'PAK3', 'PAK5']",0.6129100051158125,0,0,6
190,ATM Signaling Pathway WP2516,0.22452188992120525,1.5069922429804437,2.2511179942069175,"['CREB1', 'CRADD', 'ABL1', 'CASP2', 'TLK1', 'ATM', 'RAD9A']",0.6151350894955872,0,0,7
191,DNA Replication WP466,0.22452188992120525,1.5069922429804437,2.2511179942069175,"['ORC5', 'PRIM2', 'POLD4', 'POLA1', 'DBF4', 'ORC2', 'CDC7']",0.6151350894955872,0,0,7
192,AMP-activated protein kinase (AMPK) signaling WP1403,0.22496368987267187,1.360790273556231,2.030049067623695,"['GYS2', 'RPTOR', 'PRKAA1', 'RPS6KB1', 'INSR', 'PIK3R3', 'PIK3CB', 'CPT1C', 'EEF2', 'ACACA', 'CAMKK1']",0.6151350894955872,0,0,11
193,16p11.2 distal deletion syndrome WP4950,0.2419230193400236,1.6142763588736084,2.2908772191497753,"['PLN', 'RABEP2', 'INSR', 'JAK2', 'SDCCAG8']",0.6561939463231945,0,0,5
194,Primary focal segmental glomerulosclerosis (FSGS) WP2572,0.242479286831809,1.3323275862068966,1.8876936680988061,"['SMARCAL1', 'LAMA5', 'FYN', 'PARVA', 'VIM', 'CLDN1', 'TLR4', 'PTK2', 'CD2AP', 'LRP6', 'LIMS1']",0.6561939463231945,0,0,11
195,Nonalcoholic fatty liver disease WP4396,0.2447160353390897,1.2072481239545076,1.6993910069178195,"['COX8A', 'GSK3B', 'PRKAA1', 'INSR', 'NDUFA2', 'PIK3R3', 'UQCR11', 'PIK3CB', 'COX6A1', 'COX5B', 'COX7A1', 'VMP1', 'MLXIPL', 'MAPK8', 'ITCH', 'UQCRQ', 'NDUFS6', 'NDUFS4', 'NDUFAB1', 'CYC1', 'PPARA', 'MAP3K5']",0.6588508643744723,0,0,22
196,Prion disease pathway WP3995,0.24623356431904664,1.5161200726418118,2.124803992254883,"['CREB1', 'EP300', 'MAPK1', 'FYN', 'CHD2', 'PTK2']",0.6595541901403035,0,0,6
197,"GPCRs, Other WP117",0.24765899113914394,1.4091132674506999,1.96670293098452,"['GPR176', 'P2RY11', 'ADORA2A', 'GRM8', 'GNRHR', 'GRM1', 'DRD4', 'GPR135']",0.6600049256246222,0,0,8
198,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.253341994710411,1.2810734463276836,1.7589329878450888,"['GSK3B', 'RPS6', 'FOXO1', 'RPTOR', 'SLCO1C1', 'NHSL1', 'RPS6KB1', 'ZNF516', 'PRDM16', 'MAPK1', 'SOS1', 'RAF1', 'PPARGC1A']",0.6657517168223392,0,0,13
199,Cell-type Dependent Selectivity of CCK2R Signaling WP3679,0.2536197016466054,1.936702649656526,2.656999882006996,"['RYR1', 'TRPC1', 'GNAQ']",0.6657517168223392,0,0,3
200,FOXA2 pathway WP5066,0.2536197016466054,1.936702649656526,2.656999882006996,"['MLXIPL', 'ACACA', 'FOXO1']",0.6657517168223392,0,0,3
201,T-cell receptor (TCR) signaling pathway WP69,0.25695112494744105,1.2919336290455068,1.7555690591585416,"['MAPK8', 'CREB1', 'CHUK', 'MAPK1', 'MAP3K8', 'FYN', 'GAB2', 'VIM', 'SOS1', 'RAF1', 'CBL', 'MAP3K7']",0.6705991128323364,0,0,12
202,Oncostatin M Signaling Pathway WP2374,0.26384499654046295,1.3211136475538248,1.7602432137523008,"['STAT5B', 'MAPK8', 'CREB1', 'PRKCE', 'RPS6', 'MAPK1', 'PRKCA', 'JAK2', 'SOS1', 'RAF1']",0.6705991128323364,0,0,10
203,Purinergic signaling WP4900,0.26672636288041385,1.6601444701591976,2.1939340489672405,"['P2RY11', 'ADORA2A', 'P2RY14', 'GNAI3']",0.6705991128323364,0,0,4
204,Vitamin D in inflammatory diseases WP4482,0.26672636288041385,1.6601444701591976,2.1939340489672405,"['SMAD4', 'MAP3K1', 'CHUK', 'NR3C1']",0.6705991128323364,0,0,4
205,Adipogenesis WP236,0.2667624596089367,1.2203740301566388,1.6125981929716013,"['RB1', 'MEF2A', 'STAT5B', 'RORA', 'AHR', 'NR3C1', 'FOXO1', 'NCOR2', 'SFRP4', 'KLF7', 'RBL1', 'CREB1', 'NCOR1', 'SP1', 'SPOCK1', 'PPARA', 'PPARGC1A']",0.6705991128323364,0,0,17
206,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.26696231348944444,1.3413461538461537,1.7714458183083797,"['HELLS', 'RPS6KB1', 'HDAC1', 'CUL1', 'ABL1', 'MAPK1', 'APOE', 'VIM', 'PTK2']",0.6705991128323364,0,0,9
207,Interferon type I signaling pathways WP585,0.26696231348944444,1.3413461538461537,1.7714458183083797,"['RPTOR', 'CREB1', 'MAP3K1', 'RPS6KB1', 'RPS6', 'FYN', 'GAB2', 'CBL', 'PIAS1']",0.6705991128323364,0,0,9
208,Synaptic Vesicle Pathway WP2267,0.26696231348944444,1.3413461538461537,1.7714458183083797,"['RIMS1', 'UNC13C', 'CACNA1B', 'SLC1A3', 'PARK7', 'STX2', 'SYN2', 'SLC18A2', 'DNM2']",0.6705991128323364,0,0,9
209,The Overlap Between Signal Transduction Pathways that Contribute to a Range of LMNA Laminopathies WP4879,0.26696231348944444,1.3413461538461537,1.7714458183083797,"['RB1', 'SMAD2', 'GSK3B', 'KAT2B', 'CREBBP', 'MSTN', 'APC', 'HDAC1', 'DICER1']",0.6705991128323364,0,0,9
210,BDNF-TrkB Signaling WP3676,0.27261128421674996,1.452825552825553,1.8882495250516982,"['CREB1', 'RPS6KB1', 'MKNK1', 'MAPK1', 'GAB2', 'SOS1']",0.6711009432605144,0,0,6
211,Aspirin and miRNAs WP4707,0.2748318148590678,2.32368808239333,3.0012661179996676,"['PPARA', 'PDK1']",0.6711009432605144,0,0,2
212,DDX1 as a regulatory component of the Drosha microprocessor WP2942,0.2748318148590678,2.32368808239333,3.0012661179996676,"['DROSHA', 'ATM']",0.6711009432605144,0,0,2
213,LTF danger signal response pathway WP4478,0.2748318148590678,2.32368808239333,3.0012661179996676,"['MAPK1', 'TLR4']",0.6711009432605144,0,0,2
214,Pentose Phosphate Metabolism WP134,0.2748318148590678,2.32368808239333,3.0012661179996676,"['RPIA', 'PGD']",0.6711009432605144,0,0,2
215,Sulfation Biotransformation Reaction WP692,0.2748318148590678,2.32368808239333,3.0012661179996676,"['PAPSS2', 'PAPSS1']",0.6711009432605144,0,0,2
216,Electron Transport Chain (OXPHOS system in mitochondria) WP111,0.2921626752813647,1.2111303060217176,1.490228653757746,"['COX8A', 'COX17', 'NDUFA2', 'UQCR11', 'COX6A1', 'COX5B', 'COX7A1', 'ATP5F1D', 'ATP5F1E', 'SLC25A27', 'UQCRQ', 'NDUFS6', 'NDUFS4', 'NDUFAB1', 'ATP5ME']",0.7068451821323339,0,0,15
217,Regulation of toll-like receptor signaling pathway WP1449,0.2921626752813647,1.2111303060217176,1.490228653757746,"['MAP2K4', 'TICAM2', 'CHUK', 'PELI2', 'PIK3R3', 'PIK3CB', 'MAPK8', 'TBK1', 'TRAF3', 'TIFA', 'MAPK1', 'MAP3K8', 'ZMYND11', 'MAP3K7', 'TLR4']",0.7068451821323339,0,0,15
218,Major receptors targeted by epinephrine and norepinephrine WP4589,0.29636331916424363,1.7428851815505397,2.119643185828898,"['ADCY9', 'ADRA2C', 'ADCY5']",0.7104600116951045,0,0,3
219,miRNAs involved in DNA damage response WP1545,0.29636331916424363,1.7428851815505397,2.119643185828898,"['CREB1', 'ABL1', 'ATM']",0.7104600116951045,0,0,3
220,Pathways Regulating Hippo Signaling WP4540,0.2979592434031271,1.2146617676295386,1.4707107299844526,"['SMAD2', 'PRKAA1', 'PRKCE', 'INSR', 'GNAI3', 'PRKCA', 'EGFR', 'LATS1', 'PLCB4', 'CDH20', 'PRKAR2B', 'PRKAR2A', 'GNAQ', 'NF2']",0.7110391035756443,0,0,14
221,Serotonin Receptor 2 and ELK-SRF/GATA4 signaling WP732,0.3018113582641942,1.549337260677467,1.8560333717190485,"['GNAQ', 'MAPKAPK2', 'MAPK1', 'RAF1']",0.7139092339340933,0,0,4
222,Extracellular vesicle-mediated signaling in recipient cells WP2870,0.3018816189207023,1.4526031434184676,1.7398123145283617,"['SMAD2', 'SMAD4', 'APC', 'RAF1', 'EGFR']",0.7139092339340933,0,0,5
223,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.30922178872906103,1.275698578836182,1.4972829527942624,"['IFI27L2', 'MAPK8', 'PLCB4', 'SP1', 'PRKCE', 'SP3', 'MAPK1', 'PRKCA', 'TLR4']",0.7279885160661751,0,0,9
224,Melanoma WP4685,0.3168290506727999,1.2294240242516103,1.4130912727057774,"['RB1', 'PREX2', 'GRIN2A', 'CREB1', 'PTEN', 'PIK3R3', 'MAPK1', 'PIK3CB', 'SOS1', 'RAF1', 'SOS2']",0.7425680875143748,0,0,11
225,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.3256738881067161,1.101876886730542,1.2361502174614445,"['GSK3B', 'LAMA5', 'PRKAA1', 'PHLPP1', 'COL11A1', 'PIK3R4', 'PTEN', 'PIK3CB', 'FOXO3', 'EGFR', 'FOXO1', 'ACACA', 'RPTOR', 'GYS2', 'PPP2R5E', 'PDGFD', 'MAPK1', 'JAK2', 'PPARGC1A', 'ANGPT1', 'INSR', 'RPS6', 'FN1', 'VEGFB', 'VEGFD', 'PPP2R5C', 'PTK2', 'RAB10', 'FGF14', 'CREB1', 'COL4A2', 'RPS6KB1', 'PPP2R2D', 'ITGA8', 'RAF1', 'SOS1']",0.7456763773556904,0,0,36
226,Lipid Metabolism Pathway WP3965,0.3326890731447643,1.3833146225091215,1.5224026741187562,"['ACLY', 'PRKAA1', 'PRKAR2B', 'PRKAR2A', 'ACACA']",0.7456763773556904,0,0,5
227,White fat cell differentiation WP4149,0.3326890731447643,1.3833146225091215,1.5224026741187562,"['STAT5B', 'CREB1', 'RORA', 'NR3C1', 'FOXO1']",0.7456763773556904,0,0,5
228,Bile acids synthesis and enterohepatic circulation  WP4389,0.33308752151329746,1.9362432564982834,2.1286090166107265,"['SLC10A1', 'MAPK1']",0.7456763773556904,0,0,2
229,Leptin and adiponectin WP3934,0.33308752151329746,1.9362432564982834,2.1286090166107265,"['PRKAA1', 'ACACA']",0.7456763773556904,0,0,2
230,Mammary gland development pathway - Puberty (Stage 2 of 4) WP2814,0.33308752151329746,1.9362432564982834,2.1286090166107265,"['FN1', 'VIM']",0.7456763773556904,0,0,2
231,"Metabolic pathway of LDL, HDL and TG, including diseases WP4522",0.33308752151329746,1.9362432564982834,2.1286090166107265,"['ABCA1', 'APOE']",0.7456763773556904,0,0,2
232,Pathogenesis of SARS-CoV-2 Mediated by nsp9-nsp10 Complex WP4884,0.33308752151329746,1.9362432564982834,2.1286090166107265,"['HLA-DRA', 'FYN']",0.7456763773556904,0,0,2
233,Canonical and non-canonical Notch signaling WP3845,0.3373568269598627,1.4523809523809523,1.5781775852497808,"['CHUK', 'CNTN6', 'ADAM10', 'MAML3']",0.7456763773556904,0,0,4
234,Effect of progerin on genes involved in Hutchinson-Gilford progeria syndrome WP4320,0.3373568269598627,1.4523809523809523,1.5781775852497808,"['RB1', 'MBD3', 'HDAC1', 'SUV39H1']",0.7456763773556904,0,0,4
235,Striated Muscle Contraction Pathway WP383,0.3373568269598627,1.4523809523809523,1.5781775852497808,"['TMOD1', 'ACTA2', 'MYOM1', 'VIM']",0.7456763773556904,0,0,4
236,Glioblastoma signaling pathways WP2261,0.3391699523534374,1.1804887820512822,1.2764081736951125,"['RB1', 'MAP2K4', 'PTEN', 'PRKCA', 'PIK3CB', 'FOXO3', 'CBL', 'FOXO1', 'EGFR', 'EP300', 'MAPK1', 'ATM', 'RAF1']",0.7456763773556904,0,0,13
237,Deregulation of Rab and Rab Effector Genes in Bladder Cancer WP2291,0.3394602936914476,1.5843072531001874,1.7116828535427109,"['MYRIP', 'SYTL4', 'SYTL2']",0.7456763773556904,0,0,3
238,Differentiation of white and brown adipocyte WP2895,0.3394602936914476,1.5843072531001874,1.7116828535427109,"['ZIC1', 'PRDM16', 'PPARGC1A']",0.7456763773556904,0,0,3
239,Hypertrophy Model WP516,0.3394602936914476,1.5843072531001874,1.7116828535427109,"['ZEB1', 'MSTN', 'ADAM10']",0.7456763773556904,0,0,3
240,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.3442612668882666,1.2106105366814377,1.2909398883504293,"['STAT5B', 'MAPK8', 'CHUK', 'ANGPT1', 'FN1', 'MAPK1', 'SOS1', 'FOXO1', 'EGFR', 'PTK2']",0.7530715213180832,0,0,10
241,MicroRNAs in cardiomyocyte hypertrophy WP1544,0.34725096775683933,1.181946521205236,1.2501537124110904,"['GSK3B', 'MAP2K4', 'MAPK8', 'MYEF2', 'CHUK', 'ROCK1', 'PIK3R3', 'MAPK1', 'PIK3CB', 'RAF1', 'MYLK3', 'LRP6']",0.7564595770636541,0,0,12
242,PI3K-Akt signaling pathway WP4172,0.35029203679232745,1.0865239218532632,1.1397506443690848,"['GSK3B', 'LAMA5', 'PRKAA1', 'PHLPP1', 'PTEN', 'PIK3R3', 'PIK3CB', 'FOXO3', 'EGFR', 'RPTOR', 'GYS2', 'PPP2R5E', 'PDGFD', 'MAPK1', 'JAK2', 'CHUK', 'ANGPT1', 'INSR', 'RPS6', 'FN1', 'VEGFB', 'PRKCA', 'VEGFD', 'PPP2R5C', 'PTK2', 'FGF14', 'CREB1', 'COL4A2', 'RPS6KB1', 'PPP2R2D', 'ITGA8', 'PKN2', 'SGK1', 'RAF1', 'SOS1', 'TLR4', 'SOS2']",0.7599310715536031,0,0,37
243,Phosphoinositides metabolism WP4971,0.35486762349572687,1.291072891072891,1.337565007650007,"['PLCB4', 'PTEN', 'PIK3R4', 'PIP4K2A', 'PIK3CB', 'PLCH2']",0.7635471407182648,0,0,6
244,Target Of Rapamycin (TOR) Signaling WP1471,0.35486762349572687,1.291072891072891,1.337565007650007,"['PRR5', 'RPTOR', 'PRKAA1', 'RPS6KB1', 'ULK3', 'PRKCA']",0.7635471407182648,0,0,6
245,Oxidation by Cytochrome P450 WP43,0.3637514476162696,1.3203250580460797,1.3352242408176758,"['CYB5B', 'CYB5R4', 'CYP2U1', 'CYP4V2', 'CYP2C18']",0.7794673877491491,0,0,5
246,Retinoblastoma gene in cancer WP2446,0.36603275852661954,1.1621488417939871,1.1679972924043494,"['RB1', 'POLA1', 'ANLN', 'TFDP2', 'H2AFZ', 'HDAC1', 'SUV39H1', 'FAF1', 'ABL1', 'CDC7', 'SKP2', 'RAF1']",0.7811674724653466,0,0,12
247,Fatty Acid Biosynthesis WP357,0.37303389238301843,1.3668312685899102,1.34781317718236,"['ACLY', 'PC', 'ACSL4', 'ACACA']",0.785036694013608,0,0,4
248,IL-7 signaling pathway WP205,0.37303389238301843,1.3668312685899102,1.34781317718236,"['GSK3B', 'STAT5B', 'MAPK1', 'FYN']",0.785036694013608,0,0,4
249,B Cell Receptor Signaling Pathway WP23,0.3751098835739568,1.1445221445221445,1.1222454780365783,"['GSK3B', 'CHUK', 'GAB2', 'CBL', 'FOXO1', 'MAPK8', 'CREB1', 'MAPK1', 'FYN', 'RAF1', 'SOS1', 'MAP3K7', 'GTF2I']",0.785036694013608,0,0,13
250,Head and Neck Squamous Cell Carcinoma WP4674,0.3756219928286001,1.1620689655172414,1.1378653692873988,"['RB1', 'RPTOR', 'PRKAA1', 'SMAD4', 'TRAF3', 'RPS6', 'PTEN', 'NUMB', 'PIK3CB', 'CSMD3', 'EGFR']",0.785036694013608,0,0,11
251,Myometrial relaxation and contraction pathways WP289,0.3765808562623992,1.1069484696402063,1.081070778614539,"['RYR1', 'GUCY1A1', 'PRKCE', 'PRKCA', 'SLC8A1', 'ADCY5', 'ACTA2', 'PKIB', 'GJA1', 'ADCY9', 'CREB1', 'GRK5', 'PRKAR2B', 'GRK4', 'SP1', 'PRKAR2A', 'GNAQ', 'RGS9', 'YWHAG', 'YWHAH']",0.785036694013608,0,0,20
252,Gastric acid production WP2596,0.37921861110988975,2.903921568627451,2.815765565968911,['MUC6'],0.785036694013608,0,0,1
253,Nanomaterial-induced inflammasome activation WP3890,0.37921861110988975,2.903921568627451,2.815765565968911,['TLR4'],0.785036694013608,0,0,1
254,Mitochondrial complex III assembly WP4921,0.38235592014436115,1.4521589793915604,1.396110545331211,"['UQCRQ', 'UQCR11', 'CYC1']",0.785036694013608,0,0,3
255,Bladder cancer WP2828,0.3827988450809212,1.244857844857845,1.1953693135102035,"['RB1', 'DAPK1', 'DAPK2', 'MAPK1', 'RAF1', 'EGFR']",0.785036694013608,0,0,6
256,Signaling of Hepatocyte Growth Factor Receptor WP313,0.3827988450809212,1.244857844857845,1.1953693135102035,"['MAPK8', 'PTEN', 'MAPK1', 'SOS1', 'RAF1', 'PTK2']",0.785036694013608,0,0,6
257,Genotoxicity pathway WP4286,0.38569045680538294,1.1917212153316432,1.1353768229015992,"['ACTA2', 'TIGAR', 'DAAM1', 'BRMS1L', 'B3GNT2', 'LRRFIP2', 'PPM1D', 'PHLDA3']",0.787889065458467,0,0,8
258,Cytosine methylation WP3585,0.3898871512512975,1.6594969522875358,1.5630767566402055,"['MBD3', 'TET2']",0.7903117930769545,0,0,2
259,Estrogen Receptor Pathway WP2881,0.3898871512512975,1.6594969522875358,1.5630767566402055,"['SP1', 'PPARA']",0.7903117930769545,0,0,2
260,GABA receptor Signaling WP4159,0.39486097068771336,1.2628128470146067,1.173432909775423,"['GABRA2', 'GABRB2', 'GAD1', 'GABRG3', 'GPHN']",0.794260573222412,0,0,5
261,Host-pathogen interaction of human coronaviruses - interferon induction WP4880,0.39486097068771336,1.2628128470146067,1.173432909775423,"['MAPK8', 'TBK1', 'CHUK', 'TRAF3', 'MAP3K7']",0.794260573222412,0,0,5
262,1q21.1 copy number variation syndrome WP4905,0.40854419084307847,1.290787105220095,1.155454779281295,"['PRKAA1', 'GJA1', 'CHD1L', 'TJP2']",0.8093800007268536,0,0,4
263,Estrogen signaling pathway WP712,0.40854419084307847,1.290787105220095,1.155454779281295,"['CREB1', 'CHUK', 'SP1', 'MAPK1']",0.8093800007268536,0,0,4
264,Physiological and pathological hypertrophy of the heart WP1528,0.40854419084307847,1.290787105220095,1.155454779281295,"['MAPK8', 'MYEF2', 'PRKCE', 'MAPK1']",0.8093800007268536,0,0,4
265,Wnt/beta-catenin signaling pathway in leukemia WP3658,0.40854419084307847,1.290787105220095,1.155454779281295,"['GSK3B', 'APC', 'LRP6', 'RUNX1T1']",0.8093800007268536,0,0,4
266,BMP Signaling Pathway in Eyelid Development WP3927,0.42458143623111594,1.3403412093304143,1.1482052421749225,"['SMAD4', 'MAP3K1', 'EGFR']",0.8279930622070759,0,0,3
267,Glycosaminoglycan degradation WP4815,0.42458143623111594,1.3403412093304143,1.1482052421749225,"['IDUA', 'GLB1', 'ARSB']",0.8279930622070759,0,0,3
268,Methionine De Novo and Salvage Pathway WP3580,0.42458143623111594,1.3403412093304143,1.1482052421749225,"['MSRA', 'CHDH', 'MSRB3']",0.8279930622070759,0,0,3
269,Pregnane X receptor pathway WP2876,0.42458143623111594,1.3403412093304143,1.1482052421749225,"['ABCB1', 'PPARGC1A', 'FOXO1']",0.8279930622070759,0,0,3
270,Nuclear receptors WP170,0.4258250034207819,1.2100933202357564,1.0330891067015715,"['RARB', 'RORA', 'NR2C2', 'NR3C1', 'PPARA']",0.8279930622070759,0,0,5
271,G Protein Signaling Pathways WP35,0.4297290918586884,1.0944816053511706,0.9243994788420022,"['PRKCE', 'GNAI3', 'PRKCA', 'ADCY5', 'GNA13', 'AKAP10', 'PPP3CC', 'ADCY9', 'PRKAR2B', 'PRKAR2A', 'GNAQ', 'AKAP9', 'PDE7A']",0.8325010082133262,0,0,13
272,NO/cGMP/PKG mediated Neuroprotection WP4008,0.4385437717435478,1.1616707616707618,0.9575601562926485,"['GUCY1A2', 'GRIN2A', 'GUCY1A1', 'CREB1', 'AKAP9', 'GRIN2B']",0.8422764691334647,0,0,6
273,Notch Signaling WP268,0.4385437717435478,1.1616707616707618,0.9575601562926485,"['NCOR2', 'KAT2B', 'CREBBP', 'HDAC1', 'NUMB', 'MAML3']",0.8422764691334647,0,0,6
274,Cancer immunotherapy by CTLA4 blockade WP4582,0.4444011084761328,1.4519372241294752,1.1775613464858334,"['PIK3R3', 'PIK3CB']",0.8422764691334647,0,0,2
275,Ethanol metabolism resulting in production of ROS by CYP2E1 WP4269,0.4444011084761328,1.4519372241294752,1.1775613464858334,"['MAPK8', 'SP1']",0.8422764691334647,0,0,2
276,Osteopontin Signaling WP1434,0.4444011084761328,1.4519372241294752,1.1775613464858334,"['CHUK', 'MAPK1']",0.8422764691334647,0,0,2
277,Simplified Depiction of MYD88 Distinct Input-Output Pathway WP3877,0.4444011084761328,1.4519372241294752,1.1775613464858334,"['TIFA', 'TLR4']",0.8422764691334647,0,0,2
278,Alpha 6 Beta 4 signaling pathway WP244,0.4564677355097551,1.1615913555992141,0.9109632212674015,"['LAMA5', 'MAPK1', 'PRKCA', 'SOS1', 'PTK2']",0.8575899975689796,0,0,5
279,Apoptosis Modulation by HSP70 WP384,0.4657509332574259,1.2444974064208607,0.9509257769350088,"['MAP3K1', 'CASP6', 'CASP2']",0.8575899975689796,0,0,3
280,Activation of NLRP3 Inflammasome by SARS-CoV-2 WP4876,0.47044937009498305,1.9357843137254902,1.4597109432494495,['TRAF3'],0.8575899975689796,0,0,1
281,Cells and molecules involved in local acute inflammatory response  WP4493,0.47044937009498305,1.9357843137254902,1.4597109432494495,['C6'],0.8575899975689796,0,0,1
282,Codeine and Morphine Metabolism WP1604,0.47044937009498305,1.9357843137254902,1.4597109432494495,['ABCB1'],0.8575899975689796,0,0,1
283,Composition of Lipid Particles WP3601,0.47044937009498305,1.9357843137254902,1.4597109432494495,['APOE'],0.8575899975689796,0,0,1
284,Gene regulatory network modelling somitogenesis  WP2854,0.47044937009498305,1.9357843137254902,1.4597109432494495,['EPHA4'],0.8575899975689796,0,0,1
285,Hypothetical Craniofacial Development Pathway WP3655,0.47044937009498305,1.9357843137254902,1.4597109432494495,['ARHGAP29'],0.8575899975689796,0,0,1
286,Macrophage markers WP4146,0.47044937009498305,1.9357843137254902,1.4597109432494495,['CD74'],0.8575899975689796,0,0,1
287,Nucleotide GPCRs WP80,0.47044937009498305,1.9357843137254902,1.4597109432494495,['ADORA2A'],0.8575899975689796,0,0,1
288,Platelet-mediated interactions with vascular and circulating cells WP4462,0.47044937009498305,1.9357843137254902,1.4597109432494495,['TLR4'],0.8575899975689796,0,0,1
289,FGFR3 signaling in chondrocyte proliferation and terminal differentiation WP4767,0.4780368510860853,1.161512027491409,0.8572742262450179,"['RBL1', 'MAPK1', 'RAF1', 'ATG5']",0.8633303730782946,0,0,4
290,Monoamine GPCRs WP58,0.4780368510860853,1.161512027491409,0.8572742262450179,"['DRD1', 'HTR4', 'ADRA2C', 'DRD4']",0.8633303730782946,0,0,4
291,G1 to S cell cycle control WP45,0.48017613131211817,1.080497374712591,0.7926553615591313,"['RB1', 'ORC5', 'PRIM2', 'CREB1', 'TFDP2', 'ORC2', 'ATM', 'MNAT1']",0.8633303730782946,0,0,8
292,IL-1 signaling pathway WP195,0.48017613131211817,1.080497374712591,0.7926553615591313,"['MAP2K4', 'MAPK8', 'MAP3K1', 'CHUK', 'MAPKAPK2', 'PELI2', 'MAPK1', 'MAP3K7']",0.8633303730782946,0,0,8
293,Alanine and aspartate metabolism WP106,0.49607479949736877,1.290501880006539,0.9046786722811304,"['PC', 'GAD1']",0.8768998981014094,0,0,2
294,Development and heterogeneity of the ILC family WP3893,0.49607479949736877,1.290501880006539,0.9046786722811304,"['RORA', 'AHR']",0.8768998981014094,0,0,2
295,"NAD metabolism, sirtuins and aging WP3630",0.49607479949736877,1.290501880006539,0.9046786722811304,"['FOXO3', 'FOXO1']",0.8768998981014094,0,0,2
296,ncRNAs involved in STAT3 signaling in hepatocellular carcinoma WP4337,0.49607479949736877,1.290501880006539,0.9046786722811304,"['ZEB1', 'JAK2']",0.8768998981014094,0,0,2
297,RAS and bradykinin pathways in COVID-19 WP4969,0.49607479949736877,1.290501880006539,0.9046786722811304,"['ROCK1', 'MAPK1']",0.8768998981014094,0,0,2
298,Prader-Willi and Angelman Syndrome WP3998,0.49870323028789837,1.0697614242094913,0.7442801875703015,"['RB1', 'CYFIP1', 'GABRR2', 'HERC2', 'GNRH1', 'MSX1', 'GABRG3']",0.8785879057085457,0,0,7
299,Hippo-Yap signaling pathway WP4537,0.5055558274530996,1.161432777232581,0.7922095883777042,"['LATS1', 'NF2', 'MAP4K4']",0.8788636073274082,0,0,3
300,Host-pathogen interaction of human coronaviruses - autophagy WP4863,0.5055558274530996,1.161432777232581,0.7922095883777042,"['PIK3R4', 'ATG10', 'ATG5']",0.8788636073274082,0,0,3
301,"Relationship between inflammation, COX-2 and EGFR WP4483",0.5055558274530996,1.161432777232581,0.7922095883777042,"['MAPK1', 'PIK3CB', 'EGFR']",0.8788636073274082,0,0,3
302,Type I interferon induction and signaling during SARS-CoV-2 infection WP4868,0.5055558274530996,1.161432777232581,0.7922095883777042,"['TBK1', 'TRAF3', 'TLR4']",0.8788636073274082,0,0,3
303,Aryl Hydrocarbon Receptor Pathway WP2873,0.5115902119855318,1.1061084227505436,0.7413485321608538,"['EP300', 'ARNT', 'AHR', 'EGFR']",0.8835028331986979,0,0,4
304,Signal transduction through IL1R WP4496,0.5115902119855318,1.1061084227505436,0.7413485321608538,"['MAPK8', 'MAP3K1', 'CHUK', 'MAP3K7']",0.8835028331986979,0,0,4
305,Wnt signaling pathway and pluripotency WP399,0.5172796011751692,1.0247296552923781,0.6754728258190656,"['MAP2K4', 'GSK3B', 'CREBBP', 'APC', 'PPP2R5E', 'PRKCE', 'EP300', 'PRKCA', 'PPP2R5C', 'NLK', 'MAP3K7', 'LRP6']",0.8891873020541149,0,0,12
306,Metabolic reprogramming in colon cancer WP4290,0.5199628604392633,1.0557962921599284,0.6904885496541239,"['RPIA', 'ACLY', 'TIGAR', 'PGD', 'SLC16A3', 'PSPH']",0.8891873020541149,0,0,6
307,TGF-beta Receptor Signaling WP560,0.5199628604392633,1.0557962921599284,0.6904885496541239,"['SMAD2', 'ZEB2', 'CREBBP', 'SMAD4', 'ZFYVE9', 'EP300']",0.8891873020541149,0,0,6
308,Kallmann's Syndrome WP5074,0.5437578933370734,1.088751226692836,0.6633229698096741,"['ANOS1', 'MAPK1', 'GNRH1']",0.8939320527053116,0,0,3
309,Genes controlling nephrogenesis WP4823,0.5441176735745942,1.0557415093497569,0.6425134546944016,"['EMX2', 'NCK2', 'ITGA8', 'CD2AP']",0.8939320527053116,0,0,4
310,Resistin as a regulator of inflammation WP4481,0.5441176735745942,1.0557415093497569,0.6425134546944016,"['PLCB4', 'CHUK', 'MAPK1', 'PIK3CB']",0.8939320527053116,0,0,4
311,Dopaminergic Neurogenesis WP2855,0.5445657899989598,1.1613536047081903,0.7058318358773861,"['MSX1', 'SLC18A2']",0.8939320527053116,0,0,2
312,Galanin receptor pathway WP4970,0.5445657899989598,1.1613536047081903,0.7058318358773861,"['CREB1', 'PPARGC1A']",0.8939320527053116,0,0,2
313,Genes targeted by miRNAs in adipocytes WP1992,0.5445657899989598,1.1613536047081903,0.7058318358773861,"['GJA1', 'PTBP2']",0.8939320527053116,0,0,2
314,ID signaling pathway WP53,0.5445657899989598,1.1613536047081903,0.7058318358773861,"['RB1', 'RBL1']",0.8939320527053116,0,0,2
315,Overview of nanoparticle effects WP3287,0.5445657899989598,1.1613536047081903,0.7058318358773861,"['FN1', 'PTK2']",0.8939320527053116,0,0,2
316,Oxidative Damage WP3941,0.5449811144195496,1.0368720179623911,0.6293856048164982,"['MAP2K4', 'MAP3K1', 'TRAF3', 'TDP2', 'MAP3K9']",0.8939320527053116,0,0,5
317,Arachidonate Epoxygenase / Epoxide Hydrolase WP678,0.5482783256592578,1.4517156862745098,0.8724408095748805,['COX8A'],0.8939320527053116,0,0,1
318,FOXP3 in COVID-19 WP5063,0.5482783256592578,1.4517156862745098,0.8724408095748805,['STAT5B'],0.8939320527053116,0,0,1
319,LncRNA-mediated mechanisms of therapeutic resistance WP3672,0.5482783256592578,1.4517156862745098,0.8724408095748805,['ABCB1'],0.8939320527053116,0,0,1
320,Mitochondrial fatty acid synthesis pathway WP4317,0.5482783256592578,1.4517156862745098,0.8724408095748805,['ACACA'],0.8939320527053116,0,0,1
321,Somitogenesis in the context of spondylocostal dysostosis WP4785,0.5482783256592578,1.4517156862745098,0.8724408095748805,['EPHA4'],0.8939320527053116,0,0,1
322,Tgif disruption of Shh signaling WP3674,0.5482783256592578,1.4517156862745098,0.8724408095748805,['SMAD2'],0.8939320527053116,0,0,1
323,7q11.23 copy number variation syndrome WP4932,0.5551317923457446,0.9930836707152496,0.5844791260083839,"['RB1', 'TSG101', 'CLDN1', 'ATP5F1D', 'ACACA', 'ATP5F1E', 'USF1', 'CLIP2', 'MLXIPL', 'GTF2IRD1', 'CLASP1', 'GTF2I', 'BRD4']",0.9023039968467984,0,0,13
324,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.5706163484215077,0.9858583419997029,0.5531041791325528,"['PRKN', 'TUBB6', 'GPR37', 'PSMD14', 'FBXW7', 'RNF19A', 'CUL1', 'CASK', 'UBE2G1']",0.9235747472681343,0,0,9
325,Integrin-mediated Cell Adhesion WP185,0.571736748308845,0.9811813215418682,0.5485555405538816,"['ROCK1', 'CAPN7', 'ITGA8', 'CAPN3', 'MAPK1', 'FYN', 'RAF1', 'SOS1', 'ARHGEF7', 'PAK3', 'PTK2', 'TNS1']",0.9235747472681343,0,0,12
326,Neovascularisation processes WP4331,0.5754856932659193,1.0097543275490384,0.5579305758168508,"['SMAD2', 'MAPK8', 'ANGPT1', 'MAPK1']",0.923944920381063,0,0,4
327,Overview of leukocyte-intrinsic Hippo pathway functions WP4542,0.5754856932659193,1.0097543275490384,0.5579305758168508,"['VMP1', 'LATS1', 'FOXO3', 'FOXO1']",0.923944920381063,0,0,4
328,Phytochemical activity on NRF2 transcriptional activation WP3,0.5896934801578259,1.055686834009541,0.5575635373937512,"['MAPK8', 'PRKCA']",0.9375554861324742,0,0,2
329,PI3K/AKT/mTOR - VitD3 signaling WP4141,0.5896934801578259,1.055686834009541,0.5575635373937512,"['GSK3B', 'HLA-DRA']",0.9375554861324742,0,0,2
330,Apoptosis WP254,0.5909015637063014,0.96751968503937,0.5090177511197206,"['HELLS', 'MAP2K4', 'MAP3K1', 'CHUK', 'CRADD', 'CASP6', 'TRAF3', 'IRF2', 'CASP2']",0.9375554861324742,0,0,9
331,Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway WP4577,0.5962969825702673,0.9675675675675676,0.50024834226238,"['RPTOR', 'PRKAA1', 'PIK3R4', 'ATG10', 'ACACA', 'ATG5']",0.9375554861324742,0,0,6
332,Renin-angiotensin-aldosterone system (RAAS) WP4756,0.6055897927961225,0.96759941089838,0.48530183744457706,"['CAMK1D', 'CREB1', 'CAMK4', 'GNAQ']",0.9375554861324742,0,0,4
333,Biogenic Amine Synthesis WP550,0.6146733773010374,1.1612745098039217,0.5651507838002431,['GAD1'],0.9375554861324742,0,0,1
334,Folate-Alcohol and Cancer Pathway Hypotheses WP1589,0.6146733773010374,1.1612745098039217,0.5651507838002431,['CREB1'],0.9375554861324742,0,0,1
335,Irinotecan pathway WP229,0.6146733773010374,1.1612745098039217,0.5651507838002431,['BCHE'],0.9375554861324742,0,0,1
336,Methionine metabolism leading to sulfur amino acids and related disorders WP4292,0.6146733773010374,1.1612745098039217,0.5651507838002431,['ADK'],0.9375554861324742,0,0,1
337,MicroRNA for Targeting Cancer Growth and Vascularization in Glioblastoma WP3593,0.6146733773010374,1.1612745098039217,0.5651507838002431,['VEGFB'],0.9375554861324742,0,0,1
338,mir-124 predicted interactions with cell cycle and differentiation  WP3595,0.6146733773010374,1.1612745098039217,0.5651507838002431,['PRKAA1'],0.9375554861324742,0,0,1
339,PTF1A related regulatory pathway WP4147,0.6146733773010374,1.1612745098039217,0.5651507838002431,['KAT2B'],0.9375554861324742,0,0,1
340,Role of Altered Glycolysation of MUC1 in Tumour Microenvironment WP4480,0.6146733773010374,1.1612745098039217,0.5651507838002431,['CHUK'],0.9375554861324742,0,0,1
341,Microglia Pathogen Phagocytosis Pathway WP3937,0.6147061770571842,0.9676153091265947,0.47085214309639617,"['HCK', 'PIK3R3', 'PIK3CB']",0.9375554861324742,0,0,3
342,Type II interferon signaling (IFNG) WP619,0.6147061770571842,0.9676153091265947,0.47085214309639617,"['IRF2', 'JAK2', 'IFIT2']",0.9375554861324742,0,0,3
343,Vitamin B12 metabolism WP1533,0.6147061770571842,0.9676153091265947,0.47085214309639617,"['ABCA1', 'INSR', 'APOE']",0.9375554861324742,0,0,3
344,Novel intracellular components of RIG-I-like receptor (RLR) pathway WP3865,0.6161078908870544,0.9449703871395577,0.4576805156720071,"['MAPK8', 'TBK1', 'MAP3K1', 'CHUK', 'TRAF3', 'MAP3K7', 'ATG5']",0.9375554861324742,0,0,7
345,p53 transcriptional gene network WP4963,0.6161078908870544,0.9449703871395577,0.4576805156720071,"['TIGAR', 'DRAM1', 'PTEN', 'ERCC5', 'ACAD11', 'CPT1C', 'CX3CL1']",0.9375554861324742,0,0,7
346,TGF-beta receptor signaling in skeletal dysplasias WP4816,0.6202570281708225,0.941337406202271,0.4496028194897894,"['SMAD2', 'ZEB2', 'CREBBP', 'SMAD4', 'ZFYVE9', 'EP300']",0.9411414444788492,0,0,6
347,Ferroptosis WP4313,0.6260157848283016,0.9362919069649535,0.43854011577341107,"['TF', 'VDAC3', 'SAT2', 'ACSL4', 'ATG5']",0.9417142894981614,0,0,5
348,Hedgehog Signaling Pathway WP4249,0.6260157848283016,0.9362919069649535,0.43854011577341107,"['CSNK1G3', 'GRK3', 'SUFU', 'CDON', 'CSNK1G1']",0.9417142894981614,0,0,5
349,Nephrotic syndrome WP4758,0.6260157848283016,0.9362919069649535,0.43854011577341107,"['SMARCAL1', 'ANLN', 'PDSS2', 'GPC5', 'CD2AP']",0.9417142894981614,0,0,5
350,IL-9 signaling pathway WP22,0.6313989771647592,0.967631191760667,0.4449335840605893,"['STAT5B', 'MAPK1']",0.9417172244644847,0,0,2
351,Mammalian disorder of sexual development WP4842,0.6313989771647592,0.967631191760667,0.4449335840605893,"['EMX2', 'PBX1']",0.9417172244644847,0,0,2
352,TP53 network WP1742,0.6313989771647592,0.967631191760667,0.4449335840605893,"['ABL1', 'ATM']",0.9417172244644847,0,0,2
353,Tumor suppressor activity of SMARCB1 WP4204,0.6343521370231915,0.9288168875797742,0.42275198866331765,"['RB1', 'SMARCD3', 'EED', 'ACTL6A']",0.9434415635614037,0,0,4
354,Oxidative phosphorylation WP623,0.6377333827944766,0.9234155716456601,0.41538462362053813,"['NDUFS6', 'NDUFS4', 'NDUFA2', 'NDUFAB1', 'ATP5F1D', 'ATP5F1E', 'ATP5ME']",0.9439489516566664,0,0,7
355,"GPCRs, Class A Rhodopsin-like WP455",0.6400872891233775,0.9285362247412519,0.4142671076966574,"['GPR37', 'RABGAP1', 'P2RY11', 'OPN3', 'ADORA2A', 'P2RY14', 'RRH', 'DRD1', 'HTR4', 'ADRA2C', 'DRD4', 'GPR19']",0.9439489516566664,0,0,12
356,Small cell lung cancer WP4658,0.6400872891233775,0.9285362247412519,0.4142671076966574,"['RB1', 'LAMA5', 'CHUK', 'COL4A2', 'TRAF3', 'PTEN', 'FN1', 'RARB', 'PIK3R3', 'PIK3CB', 'FHIT', 'PTK2']",0.9439489516566664,0,0,12
357,Type I collagen synthesis in the context of Osteogenesis imperfecta WP4786,0.647258042560178,0.9166107122565983,0.3987350410560448,"['P4HA1', 'P3H2', 'LRP6']",0.9499720512672303,0,0,3
358,22q11.2 copy number variation syndrome WP4657,0.6562527868918663,0.9162408238437395,0.3859290812709369,"['ACTA2', 'PRKN', 'NCOR1', 'SERPIND1', 'DROSHA', 'SHOC2', 'ZDHHC8', 'RAF1', 'LZTR1', 'TNPO1', 'CLDN1', 'EGFR']",0.9499720512672303,0,0,12
359,Ciliary landscape WP4352,0.6618320521744214,0.9333812974287818,0.38524701952966706,"['RB1', 'TTC26', 'WDR26', 'HDAC1', 'IFT172', 'SSNA1', 'CEP170', 'CEP97', 'CEP290', 'CDR2', 'CREBBP', 'UBE2H', 'RNGTT', 'IFT140', 'DYNLT3', 'RANBP9', 'IFT122', 'ARMC8', 'DYNLL1', 'LSM4', 'IFT88', 'RABEP2', 'APC', 'WDR60', 'GLB1', 'EXOC4', 'EXOC6', 'VIM']",0.9499720512672303,0,0,28
360,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.667090414826272,0.9004887320119468,0.3645445722397211,"['SMAD2', 'GSK3B', 'RALA', 'MAPK8', 'SMAD4', 'TBK1', 'APC', 'MAPK1', 'RAF1']",0.9499720512672303,0,0,9
361,Eicosanoid metabolism via lipooxygenases (LOX) WP4721,0.6697132577464112,0.893122571396235,0.3580578686860922,"['TRPA1', 'PPARA']",0.9499720512672303,0,0,2
362,Overview of interferons-mediated signaling pathway WP4558,0.6697132577464112,0.893122571396235,0.3580578686860922,"['PRKCA', 'JAK2']",0.9499720512672303,0,0,2
363,SARS coronavirus and innate immunity WP4912,0.6697132577464112,0.893122571396235,0.3580578686860922,"['TBK1', 'TRAF3']",0.9499720512672303,0,0,2
364,TCA Cycle and Deficiency of Pyruvate Dehydrogenase complex (PDHc) WP2453,0.6697132577464112,0.893122571396235,0.3580578686860922,"['ACLY', 'PC']",0.9499720512672303,0,0,2
365,Caloric restriction and aging WP4191,0.6713135828955095,0.9676470588235294,0.385625655523932,['PPARGC1A'],0.9499720512672303,0,0,1
366,Cholesterol Biosynthesis with Skeletal Dysplasias WP4804,0.6713135828955095,0.9676470588235294,0.385625655523932,['DHCR24'],0.9499720512672303,0,0,1
367,Glucuronidation WP698,0.6713135828955095,0.9676470588235294,0.385625655523932,['PGM5'],0.9499720512672303,0,0,1
368,LDLRAD4 and what we know about it WP4904,0.6713135828955095,0.9676470588235294,0.385625655523932,['SMAD2'],0.9499720512672303,0,0,1
369,NAD Biosynthesis II (from tryptophan) WP2485,0.6713135828955095,0.9676470588235294,0.385625655523932,['HAAO'],0.9499720512672303,0,0,1
370,Serine Metabolism WP4688,0.6713135828955095,0.9676470588235294,0.385625655523932,['PSPH'],0.9499720512672303,0,0,1
371,Supression of HMGB1 mediated inflammation by THBD WP4479,0.6713135828955095,0.9676470588235294,0.385625655523932,['CHUK'],0.9499720512672303,0,0,1
372,Integrated Cancer Pathway WP1971,0.6749031151407525,0.8793981068047866,0.34576713969490513,"['RB1', 'SMAD2', 'PTEN', 'ATM', 'MAP3K5']",0.9514619536299044,0,0,5
373,Fibrin Complement Receptor 3 Signaling Pathway WP4136,0.6778033726811128,0.8707065750736016,0.3386160838550969,"['TICAM2', 'CHUK', 'TLR4']",0.9514619536299044,0,0,3
374,Sphingolipid Metabolism (integrated pathway) WP4726,0.6778033726811128,0.8707065750736016,0.3386160838550969,"['CERS5', 'CERS6', 'SGMS1']",0.9514619536299044,0,0,3
375,Apoptosis Modulation and Signaling WP1772,0.6847650059999093,0.885151141064994,0.335188641544443,"['MAPK8', 'ENDOG', 'CRADD', 'CASP6', 'TRAF3', 'PTRH2', 'CASP2', 'BIRC6', 'MAP3K5']",0.958671008399873,0,0,9
376,ESC Pluripotency Pathways WP3931,0.6873500085967754,0.8925958221177541,0.3346445658101995,"['GSK3B', 'SMAD4', 'FGF14', 'BMPR2', 'APC', 'PTEN', 'MAPK1', 'RAF1', 'SOS1', 'EGFR', 'BMPR1A', 'LRP6']",0.9597307300885827,0,0,12
377,DNA damage response WP707,0.6981929904855897,0.8642544823113454,0.3104918265814936,"['RB1', 'CREB1', 'TLK2', 'ABL1', 'TLK1', 'ATM', 'RAD9A']",0.9637922350489415,0,0,7
378,miRNA targets in ECM and membrane receptors WP2911,0.7047320520029023,0.8292580396552932,0.29018858185632,"['COL4A2', 'FN1']",0.9637922350489415,0,0,2
379,STING pathway in Kawasaki-like disease and COVID-19 WP4961,0.7047320520029023,0.8292580396552932,0.29018858185632,"['TBK1', 'CHUK']",0.9637922350489415,0,0,2
380,Intracellular trafficking proteins involved in CMT neuropathy WP4856,0.706341417786555,0.8291742604794616,0.28826787417689187,"['KIF1B', 'GDAP1', 'DNM2']",0.9637922350489415,0,0,3
381,Pyrimidine metabolism WP4022,0.7121187700449848,0.865906802766081,0.2939845118456197,"['PRIM2', 'POLD4', 'POLA1', 'PNPT1', 'NME6', 'POLR3B', 'DPYD', 'ENPP3', 'POLR2I', 'POLR2L']",0.9637922350489415,0,0,10
382,Development of ureteric collection system WP5053,0.7121552113624019,0.8290903990462164,0.2814425276157918,"['FRAS1', 'ANOS1', 'ITGA8', 'RARB']",0.9637922350489415,0,0,4
383,ATR Signaling WP3875,0.7196315355032097,0.8293417366946779,0.27286666286436184,['RAD9A'],0.9637922350489415,0,0,1
384,Canonical NF-KB pathway WP4562,0.7196315355032097,0.8293417366946779,0.27286666286436184,['CHUK'],0.9637922350489415,0,0,1
385,Cell Differentiation - Index WP2029,0.7196315355032097,0.8293417366946779,0.27286666286436184,['MEF2A'],0.9637922350489415,0,0,1
386,"Degradation pathway of sphingolipids, including diseases WP4153",0.7196315355032097,0.8293417366946779,0.27286666286436184,['GLB1'],0.9637922350489415,0,0,1
387,Hijack of ubiquitination by SARS-CoV-2 WP4860,0.7196315355032097,0.8293417366946779,0.27286666286436184,['UBA3'],0.9637922350489415,0,0,1
388,Interleukin-1 Induced Activation of NF-kappa-B WP3656,0.7196315355032097,0.8293417366946779,0.27286666286436184,['TIFA'],0.9637922350489415,0,0,1
389,Nephrogenesis WP5052,0.7196315355032097,0.8293417366946779,0.27286666286436184,['MEIS1'],0.9637922350489415,0,0,1
390,SRF and miRs in Smooth Muscle Differentiation and Proliferation WP1991,0.7196315355032097,0.8293417366946779,0.27286666286436184,['MEF2A'],0.9637922350489415,0,0,1
391,TFs regulate miRNAs related to cardiac hypertrophy WP1559,0.7196315355032097,0.8293417366946779,0.27286666286436184,['MYEF2'],0.9637922350489415,0,0,1
392,Valproic acid pathway WP3871,0.7196315355032097,0.8293417366946779,0.27286666286436184,['HDAC1'],0.9637922350489415,0,0,1
393,Sphingolipid pathway WP1422,0.7328983699886027,0.7914176108484253,0.24593162659740864,"['CERS5', 'CERS6', 'SGMS1']",0.9638540129863444,0,0,3
394,Wnt signaling in kidney disease WP4150,0.7328983699886027,0.7914176108484253,0.24593162659740864,"['INVS', 'MAPK8', 'LRP6']",0.9638540129863444,0,0,3
395,miRNA regulation of DNA damage response WP1530,0.7346199021174752,0.8288383199887625,0.2556154399110863,"['RB1', 'CREB1', 'TLK2', 'ABL1', 'TLK1', 'ATM', 'RAD9A']",0.9638540129863444,0,0,7
396,Amyotrophic lateral sclerosis (ALS) WP2447,0.7352136819172237,0.800433362111286,0.24620857828734294,"['GRIA1', 'PPP3CC', 'ALS2', 'MAP3K5']",0.9638540129863444,0,0,4
397,Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells WP4301,0.7365961625889117,0.7739087788131437,0.23659589735997388,"['MAPK1', 'RAF1']",0.9638540129863444,0,0,2
398,Nanomaterial induced apoptosis WP2507,0.7365961625889117,0.7739087788131437,0.23659589735997388,"['ENDOG', 'CASP6']",0.9638540129863444,0,0,2
399,Nicotine Activity on Dopaminergic Neurons WP1602,0.7365961625889117,0.7739087788131437,0.23659589735997388,"['SLC18A2', 'DRD4']",0.9638540129863444,0,0,2
400,Nucleotide metabolism WP404,0.7365961625889117,0.7739087788131437,0.23659589735997388,"['POLA1', 'POLG']",0.9638540129863444,0,0,2
401,Regulation of apoptosis by parathyroid hormone-related protein WP3872,0.7365961625889117,0.7739087788131437,0.23659589735997388,"['GSK3B', 'BCL2L14']",0.9638540129863444,0,0,2
402,ATM Signaling Network in Development and Disease  WP3878,0.7398726994923749,0.8059102815979043,0.2428023409449199,"['PRKAA1', 'ATM', 'PPM1D', 'MAP3K5', 'CDK5R1']",0.9638540129863444,0,0,5
403,Complement system WP2806,0.7398726994923749,0.8059102815979043,0.2428023409449199,"['LAMA5', 'FKBP2', 'C6', 'GNAI3', 'PRKCA']",0.9638540129863444,0,0,5
404,Breast cancer pathway WP4262,0.7430086077207466,0.8612541905720681,0.25583353271011255,"['RB1', 'GSK3B', 'PTEN', 'PIK3R3', 'EGFR', 'LRP6', 'SFRP4', 'RPS6KB1', 'APC', 'SP1', 'MAPK1', 'ATM', 'RAF1', 'SOS1', 'SOS2']",0.9655433639935446,0,0,15
405,Osteoblast differentiation WP4787,0.750012720529294,0.8394736842105263,0.24148729129703644,"['SMAD4', 'MAPK8', 'BMPR2', 'PRKCE', 'PIK3R4', 'PIK3R3', 'MAPK1', 'PRKCA', 'PIK3CB', 'BMPR1A', 'LRP6']",0.9694338242069607,0,0,11
406,Endothelin Pathways WP2197,0.7575219079303932,0.756944148141827,0.21020552501847165,"['MAPK1', 'PRKCA', 'RAF1']",0.9694338242069607,0,0,3
407,Tryptophan metabolism WP465,0.7575219079303932,0.756944148141827,0.21020552501847165,"['HAAO', 'DHCR24', 'CYP2C18']",0.9694338242069607,0,0,3
408,Photodynamic therapy-induced AP-1 survival signaling. WP3611,0.7592748005203992,0.7840625497796421,0.2159241703739654,"['RB1', 'MAP2K4', 'MAPK8', 'EGFR', 'MAP3K5']",0.9694338242069607,0,0,5
409,15q11.2 copy number variation syndrome WP4940,0.7608495265305087,0.7256127450980392,0.19832423742129643,['CYFIP1'],0.9694338242069607,0,0,1
410,Cytokines and Inflammatory Response WP530,0.7608495265305087,0.7256127450980392,0.19832423742129643,['HLA-DRA'],0.9694338242069607,0,0,1
411,Osteoclast Signaling WP12,0.7608495265305087,0.7256127450980392,0.19832423742129643,['MAPK8'],0.9694338242069607,0,0,1
412,Mitochondrial complex I assembly model OXPHOS system WP4324,0.7631931878028064,0.7911101183828456,0.21379282985731257,"['NDUFS6', 'NUBPL', 'NDUFAF4', 'NDUFS4', 'NDUFA2', 'NDUFAB1']",0.9694338242069607,0,0,6
413,One-carbon metabolism WP241,0.7654761649617349,0.7254781755762629,0.19388926654120175,"['CHDH', 'DNMT3A']",0.9694338242069607,0,0,2
414,Regulatory circuits of the STAT3 signaling pathway WP4538,0.7678687483986183,0.7961998958875586,0.21030542271825614,"['RPTOR', 'MAPK8', 'CREBBP', 'IL5RA', 'MAPK1', 'JAK2', 'EGFR']",0.9694338242069607,0,0,7
415,mRNA Processing WP411,0.7731438634144361,0.84327721661055,0.21696691077099572,"['SRPK2', 'RBM39', 'RNGTT', 'FUS', 'SFSWAP', 'CELF4', 'PRPF4B', 'DICER1', 'PTBP2', 'SRPK1', 'PRPF18', 'DHX15', 'DHX38', 'SRSF4', 'SREK1', 'RBM5']",0.9694338242069607,0,0,16
416,Immune response to tuberculosis WP4197,0.791560627194024,0.6827452903672504,0.1595908955719724,"['JAK2', 'PIAS1']",0.9694338242069607,0,0,2
417,Metabolism of Spingolipids in ER and Golgi apparatus WP4142,0.791560627194024,0.6827452903672504,0.1595908955719724,"['GALNT16', 'ST6GALNAC3']",0.9694338242069607,0,0,2
418,Ovarian infertility WP34,0.791560627194024,0.6827452903672504,0.1595908955719724,"['NCOR1', 'ATM']",0.9694338242069607,0,0,2
419,Statin inhibition of cholesterol production WP430,0.791560627194024,0.6827452903672504,0.1595908955719724,"['ABCA1', 'APOE']",0.9694338242069607,0,0,2
420,Cytosolic DNA-sensing pathway WP4655,0.7947692785017858,0.7437282756536194,0.17083693008190318,"['TBK1', 'CHUK', 'POLR3B', 'ATG5', 'POLR2L']",0.9694338242069607,0,0,5
421,Hepatitis C and Hepatocellular Carcinoma WP3646,0.7959755422438369,0.7252086401570937,0.16548305302359576,"['MAPK8', 'SMAD4', 'COL4A2', 'SOS1']",0.9694338242069607,0,0,4
422,Complement Activation WP545,0.7960104042429054,0.6449346405228759,0.147137338246572,['C6'],0.9694338242069607,0,0,1
423,Iron metabolism in placenta WP2007,0.7960104042429054,0.6449346405228759,0.147137338246572,['TF'],0.9694338242069607,0,0,1
424,Nanoparticle triggered regulated necrosis WP2513,0.7960104042429054,0.6449346405228759,0.147137338246572,['MAPK8'],0.9694338242069607,0,0,1
425,TCA cycle in senescence WP5050,0.7960104042429054,0.6449346405228759,0.147137338246572,['PDK1'],0.9694338242069607,0,0,1
426,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.8012387638735992,0.696270853778214,0.15429104088170748,"['ACAP1', 'CHUK', 'ERBIN']",0.9694338242069607,0,0,3
427,Peptide GPCRs WP24,0.8012387638735992,0.696270853778214,0.15429104088170748,"['ATP8A1', 'GNRHR', 'TAC4']",0.9694338242069607,0,0,3
428,The influence of laminopathies on Wnt signaling WP4844,0.8012387638735992,0.696270853778214,0.15429104088170748,"['GSK3B', 'APC', 'DICER1']",0.9694338242069607,0,0,3
429,ncRNAs involved in Wnt signaling in hepatocellular carcinoma WP4336,0.8118577598693809,0.7517753741942532,0.1566926365230339,"['GSK3B', 'SFRP4', 'APC', 'NOTUM', 'NLK', 'CXXC4', 'LRP6']",0.9694338242069607,0,0,7
430,SARS-CoV-2 innate immunity evasion and cell-specific immune response WP5039,0.8135478568048962,0.7031731155442495,0.14510014210301142,"['TBK1', 'TRAF3', 'EP300', 'IFIT2']",0.9694338242069607,0,0,4
431,LncRNA involvement in canonical Wnt signaling and colorectal cancer WP4258,0.8139375490042629,0.7605009152266294,0.1565655683940541,"['GSK3B', 'SFRP4', 'APC', 'NOTUM', 'NLK', 'MAP3K7', 'CXXC4', 'LRP6']",0.9694338242069607,0,0,8
432,miRNA regulation of p53 pathway in prostate cancer WP3982,0.8150471464262167,0.6447605035147949,0.13185953151686075,"['PTEN', 'ATM']",0.9694338242069607,0,0,2
433,NAD Metabolism in Oncogene-Induced Senescence and Mitochondrial Dysfunction-Associated Senescence WP5046,0.8150471464262167,0.6447605035147949,0.13185953151686075,"['RB1', 'PRKAA1']",0.9694338242069607,0,0,2
434,Trans-sulfuration and one-carbon metabolism WP2525,0.8150471464262167,0.6447605035147949,0.13185953151686075,"['DNMT3A', 'PSPH']",0.9694338242069607,0,0,2
435,Zinc homeostasis WP3529,0.8150471464262167,0.6447605035147949,0.13185953151686075,"['SLC39A11', 'SLC39A12']",0.9694338242069607,0,0,2
436,Glycolysis and Gluconeogenesis WP534,0.8204948803555474,0.6694345889635389,0.1324460322296945,"['PC', 'ALDOC', 'PFKP']",0.9694338242069607,0,0,3
437,Cancer immunotherapy by PD-1 blockade WP4585,0.8260039068571916,0.5803921568627451,0.11094531290945658,['NFAT5'],0.9694338242069607,0,0,1
438,Mammary gland development pathway - Embryonic development (Stage 1 of 4) WP2813,0.8260039068571916,0.5803921568627451,0.11094531290945658,['ZEB2'],0.9694338242069607,0,0,1
439,RalA downstream regulated genes WP2290,0.8260039068571916,0.5803921568627451,0.11094531290945658,['RALA'],0.9694338242069607,0,0,1
440,Regulation of sister chromatid separation at the metaphase-anaphase transition WP4240,0.8260039068571916,0.5803921568627451,0.11094531290945658,['ANAPC11'],0.9694338242069607,0,0,1
441,Serotonin and anxiety-related events WP3944,0.8260039068571916,0.5803921568627451,0.11094531290945658,['NLGN1'],0.9694338242069607,0,0,1
442,Modulators of TCR signaling and T cell activation WP5072,0.8260202221421071,0.7073290526618429,0.13519606260765038,"['GNA13', 'CHUK', 'RASA2', 'MAP3K8', 'ZFP36L1']",0.9694338242069607,0,0,5
443,Allograft Rejection WP2328,0.8298589750547678,0.6824337982615727,0.12727356366046308,"['ABCB1', 'C6', 'HLA-DRA', 'VIM']",0.9694338242069607,0,0,4
444,One-carbon metabolism and related pathways WP3940,0.8298589750547678,0.6824337982615727,0.12727356366046308,"['CHDH', 'GAD1', 'DNMT3A', 'PLD1']",0.9694338242069607,0,0,4
445,Nuclear Receptors Meta-Pathway WP2882,0.8343347040194224,0.8318659775441097,0.1506680927300275,"['ABCB1', 'ABHD2', 'CUL1', 'AHR', 'NR3C1', 'EGFR', 'FOXO1', 'EPB41L4B', 'EP300', 'PPARGC1A', 'TXNRD3', 'SLC10A1', 'NCOA6', 'SLC39A11', 'ARNT', 'SLC39A12', 'PGD', 'SLC6A6', 'KAT2B', 'SLC6A7', 'SLC6A9', 'SP1', 'PPARA', 'EPHA3', 'CPEB4', 'FKBP5']",0.9694338242069607,0,0,26
446,Glycerolipids and Glycerophospholipids WP4722,0.8361356282684171,0.6107741152783872,0.10930685012460493,"['PLD1', 'AGPAT4']",0.9694338242069607,0,0,2
447,Unfolded protein response WP4925,0.8361356282684171,0.6107741152783872,0.10930685012460493,"['CASP2', 'ATF6']",0.9694338242069607,0,0,2
448,Endochondral Ossification with Skeletal Dysplasias WP4808,0.8401359307247372,0.690429413415661,0.12026698898267944,"['ACAN', 'STAT5B', 'IFT88', 'SOX5', 'BMPR1A']",0.9694338242069607,0,0,5
449,Endochondral Ossification WP474,0.8401359307247372,0.690429413415661,0.12026698898267944,"['ACAN', 'STAT5B', 'IFT88', 'SOX5', 'BMPR1A']",0.9694338242069607,0,0,5
450,Sterol regulatory element-binding proteins (SREBP) signaling WP1982,0.8491075381758175,0.7120271179423485,0.11646587422244283,"['ACLY', 'PRKAA1', 'CREB1', 'SP1', 'SEC24D', 'ATF6', 'ACACA']",0.9694338242069607,0,0,7
451,Biomarkers for pyrimidine metabolism disorders WP4584,0.8515891322008752,0.5275846702317291,0.08475706166159024,['DPYD'],0.9694338242069607,0,0,1
452,BMP2-WNT4-FOXO1 pathway in primary endometrial stromal cell differentiation WP3876,0.8515891322008752,0.5275846702317291,0.08475706166159024,['FOXO1'],0.9694338242069607,0,0,1
453,Cell Differentiation - Index expanded WP2023,0.8515891322008752,0.5275846702317291,0.08475706166159024,['MEF2A'],0.9694338242069607,0,0,1
454,Hedgehog Signaling Pathway Netpath WP47,0.8515891322008752,0.5275846702317291,0.08475706166159024,['SUFU'],0.9694338242069607,0,0,1
455,Interactions between immune cells and microRNAs in tumor microenvironment WP4559,0.8515891322008752,0.5275846702317291,0.08475706166159024,['TLR4'],0.9694338242069607,0,0,1
456,NO metabolism in cystic fibrosis WP4947,0.8515891322008752,0.5275846702317291,0.08475706166159024,['DDAH1'],0.9694338242069607,0,0,1
457,Glucocorticoid Receptor Pathway WP2880,0.8532956536019044,0.6743158039018595,0.10697965412881803,"['EPB41L4B', 'ABHD2', 'CUL1', 'NR3C1', 'CPEB4']",0.9694338242069607,0,0,5
458,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.8542593110416213,0.6215126875087621,0.09790098206941948,"['EGLN1', 'ANGPT1', 'ARNT']",0.9694338242069607,0,0,3
459,7-oxo-C and 7beta-HC pathways WP5064,0.8550233455063053,0.5801863658656204,0.09087256315911528,"['ACOT9', 'ACOT6']",0.9694338242069607,0,0,2
460,SARS-CoV-2 mitochondrial interactions WP5038,0.8550233455063053,0.5801863658656204,0.09087256315911528,"['TBK1', 'TRAF3']",0.9694338242069607,0,0,2
461,Signal Transduction of S1P Receptor WP26,0.8550233455063053,0.5801863658656204,0.09087256315911528,"['GNAI3', 'MAPK1']",0.9694338242069607,0,0,2
462,Sphingolipid Metabolism (general overview) WP4725,0.8550233455063053,0.5801863658656204,0.09087256315911528,"['CERS6', 'SGMS1']",0.9694338242069607,0,0,2
463,DNA IR-damage and cellular response via ATR WP4016,0.8594732597668022,0.7134587006697188,0.1080430221718303,"['SMARCAL1', 'BRIP1', 'HERC2', 'POLN', 'SP1', 'ATM', 'PPM1D', 'RAD9A']",0.9694338242069607,0,0,8
464,Prostaglandin Synthesis and Regulation WP98,0.8689597017875327,0.600030455822138,0.08427939450725506,"['SCGB1A1', 'ANXA6', 'PPARGC1A']",0.9694338242069607,0,0,3
465,Cell migration and invasion through p75NTR WP4561,0.8719013966706395,0.5525117354445457,0.0757377223026721,"['TIAM1', 'KIDINS220']",0.9694338242069607,0,0,2
466,Cori Cycle WP1946,0.8734137120950332,0.483578431372549,0.06545037657453703,['PFKP'],0.9694338242069607,0,0,1
467,Fatty acid transporters WP5061,0.8734137120950332,0.483578431372549,0.06545037657453703,['ACSL4'],0.9694338242069607,0,0,1
468,GPR40 Pathway WP3958,0.8734137120950332,0.483578431372549,0.06545037657453703,['PKD1'],0.9694338242069607,0,0,1
469,H19 action Rb-E2F1 signaling and CDK-Beta-catenin activity WP3969,0.8734137120950332,0.483578431372549,0.06545037657453703,['RB1'],0.9694338242069607,0,0,1
470,Omega-3/Omega-6 FA synthesis WP4723,0.8734137120950332,0.483578431372549,0.06545037657453703,['ACSL4'],0.9694338242069607,0,0,1
471,Omega-9 FA synthesis WP4724,0.8734137120950332,0.483578431372549,0.06545037657453703,['ACSL4'],0.9694338242069607,0,0,1
472,Pyrimidine metabolism and related diseases WP4225,0.8734137120950332,0.483578431372549,0.06545037657453703,['DPYD'],0.9694338242069607,0,0,1
473,Tryptophan catabolism leading to NAD+ production WP4210,0.8734137120950332,0.483578431372549,0.06545037657453703,['HAAO'],0.9694338242069607,0,0,1
474,Cholesterol metabolism (includes both Bloch and Kandutsch-Russell pathways) WP4718,0.8836357024974172,0.6103919592796424,0.0755118349828361,"['ABCA1', 'ELOVL4', 'DHCR24', 'ACSL4']",0.977694865767669,0,0,4
475,Ethanol effects on histone modifications WP3996,0.8869522624976106,0.5273529805162959,0.06326343474805259,"['KAT2B', 'HDAC1']",0.977694865767669,0,0,2
476,DNA IR-double strand breaks and cellular response via ATM WP3959,0.8874545964353461,0.6301785256684035,0.07524200386210755,"['LATS1', 'ACTL6A', 'ABL1', 'ATM', 'RAD9A']",0.977694865767669,0,0,5
477,GDNF/RET signaling axis WP4830,0.8920301727670733,0.446342383107089,0.050996992258768505,['GREM1'],0.977694865767669,0,0,1
478,Riboflavin and CoQ disorders WP5037,0.8920301727670733,0.446342383107089,0.050996992258768505,['PDSS2'],0.977694865767669,0,0,1
479,Serotonin and anxiety WP3947,0.8920301727670733,0.446342383107089,0.050996992258768505,['GRM1'],0.977694865767669,0,0,1
480,Nucleotide Excision Repair WP4753,0.904489057265927,0.5797741777123221,0.058200672760583834,"['CUL4A', 'POLD4', 'ERCC5', 'MNAT1']",0.9838002625591098,0,0,4
481,Photodynamic therapy-induced NF-kB survival signaling WP3617,0.9079098956186651,0.4144257703081233,0.040037731359607795,['CHUK'],0.9838002625591098,0,0,1
482,PPAR-alpha pathway WP2878,0.9079098956186651,0.4144257703081233,0.040037731359607795,['PPARA'],0.9838002625591098,0,0,1
483,Cardiac Progenitor Differentiation WP2406,0.9122503630465322,0.48332515939185877,0.04438897205237911,"['GSK3B', 'MYLK3']",0.9838002625591098,0,0,2
484,Complement and Coagulation Cascades WP558,0.9122503630465322,0.48332515939185877,0.04438897205237911,"['C6', 'SERPIND1']",0.9838002625591098,0,0,2
485,Oxysterols derived from cholesterol WP4545,0.9122503630465322,0.48332515939185877,0.04438897205237911,"['ACOT9', 'ACOT6']",0.9838002625591098,0,0,2
486,Pre-implantation embryo WP3527,0.9122503630465322,0.48332515939185877,0.04438897205237911,"['ZFP36L2', 'PBX1']",0.9838002625591098,0,0,2
487,Neural Crest Differentiation WP2064,0.9169010891451096,0.6100090521143152,0.05292174772563743,"['GSK3B', 'HDAC1', 'ZIC1', 'MSX1', 'SOX5', 'GFAP']",0.9838002625591098,0,0,6
488,Globo Sphingolipid Metabolism WP1424,0.9214550291987648,0.38676470588235295,0.03163785759205192,['ST6GALNAC3'],0.9838002625591098,0,0,1
489,"GPCRs, Class B Secretin-like WP334",0.9214550291987648,0.38676470588235295,0.03163785759205192,['ADGRG2'],0.9838002625591098,0,0,1
490,Mitochondrial LC-Fatty Acid Beta-Oxidation WP368,0.9214550291987648,0.38676470588235295,0.03163785759205192,['ACSL4'],0.9838002625591098,0,0,1
491,Urea cycle and metabolism of amino groups WP497,0.9214550291987648,0.38676470588235295,0.03163785759205192,['ALDH18A1'],0.9838002625591098,0,0,1
492,Exercise-induced Circadian Regulation WP410,0.9219613889125371,0.5520723753418894,0.044856948114868456,"['NCKAP1', 'ZFR', 'CLOCK', 'ETV6']",0.9838002625591098,0,0,4
493,Proximal tubule transport WP4917,0.9244283428836554,0.5115742077007447,0.040199368338507895,"['ABCB1', 'SLC20A2', 'SLC4A2']",0.9844318053020671,0,0,3
494,Differentiation Pathway WP2848,0.9321596975149842,0.44607084920964274,0.03133698108774335,"['ALK', 'TF']",0.9886542246371044,0,0,2
495,TYROBP causal network in microglia WP3945,0.9321596975149842,0.44607084920964274,0.03133698108774335,"['DPYD', 'ZFP36L2']",0.9886542246371044,0,0,2
496,Folate Metabolism WP176,0.9477378376908393,0.41413858333917186,0.022229864789235155,"['ABCA1', 'INSR']",0.9973052444612657,0,0,2
497,NAD+ biosynthetic pathways WP3645,0.9512691111866917,0.32222222222222224,0.016097667808096332,['TNKS'],0.9973052444612657,0,0,1
498,Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling WP3612,0.9512691111866917,0.32222222222222224,0.016097667808096332,['MAPK8'],0.9973052444612657,0,0,1
499,Triacylglyceride synthesis WP325,0.9512691111866917,0.32222222222222224,0.016097667808096332,['AGPAT4'],0.9973052444612657,0,0,1
500,Amino Acid metabolism WP3925,0.9517149210481984,0.5516321516321516,0.02730013270659504,"['ACLY', 'PC', 'HIBADH', 'AUH', 'MARS2', 'ALDH18A1']",0.9973052444612657,0,0,6
501,Vitamin A and carotenoid metabolism WP716,0.954184594426254,0.3998241193282711,0.01875100394357535,"['MAPK1', 'RARB']",0.9973052444612657,0,0,2
502,Eukaryotic Transcription Initiation WP405,0.9575618375046812,0.44579904884124705,0.019332065839481914,"['POLR3B', 'POLR2I', 'MNAT1']",0.9973052444612657,0,0,3
503,Monoamine Transport WP727,0.9584386367404708,0.30523735810113517,0.012957246074318285,['ADORA2A'],0.9973052444612657,0,0,1
504,Urea cycle and associated pathways WP4595,0.9584386367404708,0.30523735810113517,0.012957246074318285,['SLC25A12'],0.9973052444612657,0,0,1
505,"Oligodendrocyte specification and differentiation, leading to myelin components for CNS WP4304",0.9645537368203556,0.2899509803921569,0.010464253609384546,['SOX5'],0.9973052444612657,0,0,1
506,Fluoropyrimidine Activity WP1601,0.969769420858304,0.2761204481792717,0.008476054541836664,['DPYD'],0.9973052444612657,0,0,1
507,DNA Mismatch Repair WP531,0.9742179197665342,0.26354723707664884,0.00688392326089109,['POLD4'],0.9973052444612657,0,0,1
508,Hair Follicle Development: Organogenesis - Part 2 of 3 WP2839,0.9742179197665342,0.26354723707664884,0.00688392326089109,['LAMA5'],0.9973052444612657,0,0,1
509,NRF2 pathway WP2884,0.9746086060779239,0.5382811516947117,0.013844224244329696,"['SLC6A6', 'SLC6A7', 'SLC6A9', 'TXNRD3', 'SLC39A11', 'SLC39A12', 'PGD', 'EPHA3']",0.9973052444612657,0,0,8
510,16p11.2 proximal deletion syndrome WP4949,0.976533230984143,0.4669180556435769,0.011087668926036178,"['KMT2C', 'PTEN', 'NR3C1', 'EZR', 'BPTF']",0.9973052444612657,0,0,5
511,PPAR signaling pathway WP3942,0.9766772374406161,0.3949727897225444,0.00932097960347822,"['ACSL4', 'CPT1C', 'PPARA']",0.9973052444612657,0,0,3
512,Gastric Cancer Network 2 WP2363,0.9780120325622144,0.25206734867860187,0.00560429044275916,['EGFR'],0.9973052444612657,0,0,1
513,Oxidative Stress WP408,0.9780120325622144,0.25206734867860187,0.00560429044275916,['SP1'],0.9973052444612657,0,0,1
514,Photodynamic therapy-induced unfolded protein response WP3613,0.9780120325622144,0.25206734867860187,0.00560429044275916,['ATF6'],0.9973052444612657,0,0,1
515,Vitamin D Receptor Pathway WP2877,0.9790928160361818,0.5063298918387414,0.01069816021501443,"['ABCB1', 'CLEC16A', 'CDKAL1', 'ASAP2', 'TRAK1', 'SLC8A1', 'FOXO1']",0.9973052444612657,0,0,7
516,Glycosylation and related congenital defects WP4521,0.9812479801373116,0.24154411764705883,0.004572446655736515,['TUSC3'],0.9973052444612657,0,0,1
517,Selenium Micronutrient Network WP15,0.9838568178552713,0.36966780114004133,0.006016307541906045,"['ABCA1', 'TXNRD3', 'INSR']",0.9973052444612657,0,0,3
518,Glycerophospholipid Biosynthetic Pathway WP2533,0.9840078412017821,0.23186274509803922,0.003737955133470879,['PIK3CB'],0.9973052444612657,0,0,1
519,Lung fibrosis WP3624,0.9900810971441154,0.20696778711484592,0.002063142428901143,['GREM1'],0.9995600274813871,0,0,1
520,Base Excision Repair WP4752,0.9915411708503096,0.19981406355645706,0.0016973821219454345,['POLD4'],0.9995600274813871,0,0,1
521,DNA Repair Pathways Full Network WP4946,0.9921863054281441,0.4860870925012878,0.0038130525664871384,"['CUL4A', 'POLD4', 'BRIP1', 'FANCM', 'ATM', 'ERCC5', 'FANCB', 'MNAT1', 'RAD54B']",0.9995600274813871,0,0,9
522,Fatty acid beta-oxidation WP143,0.9938482558957791,0.18689120809614168,0.001153257809217534,['ACSL4'],0.9995600274813871,0,0,1
523,Metapathway biotransformation Phase I and II WP702,0.9980618333155352,0.3687385644832453,0.0007153702785366499,"['NAA50', 'CYP2U1', 'CYP4V2', 'HS6ST1', 'CYP2C18', 'HS6ST3']",0.9998828809581625,0,0,6
524,Translation Factors WP107,0.9996997730501738,0.11568627450980393,3.473735213844106e-05,['EEF2'],0.9998828809581625,0,0,1
525,Proteasome Degradation WP183,0.9998828809581625,0.10323879551820728,1.2091936923409346e-05,['H2AFZ'],0.9998828809581625,0,0,1
